<?xml version="1.0" encoding="UTF-8"?>
<OnkostarEditor><InfoXML><Name>OnkoStar</Name><Version>2.9.6</Version></InfoXML><Editor><PropertyCatalogue><Name>drugClass</Name><Description>from NCT-POT Drugs</Description><Standard>SIMPLE</Standard><Readonly>false</Readonly><Anmerkung>For more informations see https://github.com/TMO-HD/NCT-POT</Anmerkung><SID>0</SID><Versions><Version><ValidFrom>2023-03-30+01:00</ValidFrom><OID>NCT-POT DrugClass.2023-03</OID><Active>true</Active><Description>NCT-POT Drugs (v2023-03)</Description><Entries><Entry><Code>Aminop_5bZ</Code><ShortDescription>Aminopeptidase inhibitor</ShortDescription><Description>DCLA-000037</Description><Synonyms/><Note>Tosedostat</Note><Position>1.0</Position></Entry><Entry><Code>CD19 ab</Code><ShortDescription>CD19 antibody</ShortDescription><Description>DCLA-000043</Description><Synonyms/><Note>Tafasitamab</Note><Position>2.0</Position></Entry><Entry><Code>CD22 ab</Code><ShortDescription>CD22 antibody</ShortDescription><Description>DCLA-000046</Description><Synonyms/><Note>Epratuzumab</Note><Position>3.0</Position></Entry><Entry><Code>CD27 ab</Code><ShortDescription>CD27 antibody</ShortDescription><Description>DCLA-000047</Description><Synonyms/><Note>Varlilumab</Note><Position>4.0</Position></Entry><Entry><Code>CD37 ab</Code><ShortDescription>CD37 antibody</ShortDescription><Description>DCLA-000051</Description><Synonyms/><Note>Otlertuzumab Lilotomab</Note><Position>5.0</Position></Entry><Entry><Code>CD46 ab</Code><ShortDescription>CD46 antibody</ShortDescription><Description>DCLA-000307</Description><Synonyms/><Note>Anti-CD46 Monoclonal Antibody YS5</Note><Position>6.0</Position></Entry><Entry><Code>CD79B ab</Code><ShortDescription>CD79B antibody</ShortDescription><Description>DCLA-000054</Description><Synonyms/><Note>Polatuzumab Vedotin</Note><Position>7.0</Position></Entry><Entry><Code>CD194 ab</Code><ShortDescription>CD194 antibody</ShortDescription><Description>DCLA-000044</Description><Synonyms/><Note>Mogamulizumab</Note><Position>8.0</Position></Entry><Entry><Code>DKK1 ab</Code><ShortDescription>DKK1 antibody</ShortDescription><Description>DCLA-000057</Description><Synonyms/><Note>Anti-DKK1 Monoclonal Antibody BHQ880</Note><Position>9.0</Position></Entry><Entry><Code>EpCAM ab</Code><ShortDescription>EpCAM antibody</ShortDescription><Description>DCLA-000059</Description><Synonyms/><Note>Catumaxomab Edrecolomab</Note><Position>10.0</Position></Entry><Entry><Code>GD2 ab</Code><ShortDescription>GD2 antibody</ShortDescription><Description>DCLA-000062</Description><Synonyms/><Note>Dinutuximab</Note><Position>11.0</Position></Entry><Entry><Code>KIR ab</Code><ShortDescription>KIR antibody</ShortDescription><Description>DCLA-000071</Description><Synonyms/><Note>Anti-KIR Monoclonal Antibody IPH 2101</Note><Position>12.0</Position></Entry><Entry><Code>P-sele_gYI</Code><ShortDescription>P-selectin antibody</ShortDescription><Description>DCLA-000078</Description><Synonyms/><Note>Crizanlizumab</Note><Position>13.0</Position></Entry><Entry><Code>PS ab</Code><ShortDescription>PS antibody</ShortDescription><Description>DCLA-000082</Description><Synonyms/><Note>Bavituximab</Note><Position>14.0</Position></Entry><Entry><Code>VEGFR ab</Code><ShortDescription>VEGFR antibody</ShortDescription><Description>DCLA-000089</Description><Synonyms/><Note>Ramucirumab</Note><Position>15.0</Position></Entry><Entry><Code>Calcin_HIG</Code><ShortDescription>Calcineurin inhibitor</ShortDescription><Description>DCLA-000113</Description><Synonyms/><Note>Tacrolimus</Note><Position>16.0</Position></Entry><Entry><Code>Microt_kDr</Code><ShortDescription>Microtubule inhibitor</ShortDescription><Description>DCLA-000169</Description><Synonyms/><Note>Vindesine Vinflunine Docetaxel Eribulin Ixabepilone Paclitaxel Vinblastine Vincristine Vinorelbine</Note><Position>17.0</Position></Entry><Entry><Code>PAR1 i</Code><ShortDescription>PAR1 inhibitor</ShortDescription><Description>DCLA-000174</Description><Synonyms/><Note>Vorapaxar</Note><Position>18.0</Position></Entry><Entry><Code>Purine_o6e</Code><ShortDescription>Purine nucleoside phosphorylase (PNP)  inhibitor</ShortDescription><Description>DCLA-000194</Description><Synonyms/><Note>Forodesine</Note><Position>19.0</Position></Entry><Entry><Code>Retinoid</Code><ShortDescription>Retinoid</ShortDescription><Description>DCLA-000200</Description><Synonyms/><Note>Bexarotene Isotretinoin Tamibarotene</Note><Position>20.0</Position></Entry><Entry><Code>Telome_vIx</Code><ShortDescription>Telomerase inhibitor</ShortDescription><Description>DCLA-000214</Description><Synonyms/><Note>Imetelstat</Note><Position>21.0</Position></Entry><Entry><Code>XPO1 i</Code><ShortDescription>XPO1 inhibitor</ShortDescription><Description>DCLA-000232</Description><Synonyms/><Note>Selinexor</Note><Position>22.0</Position></Entry><Entry><Code>AKT i</Code><ShortDescription>AKT inhibitor</ShortDescription><Description>DCLA-000008</Description><Synonyms/><Note>Afuresertib Capivasertib Ipatasertib Perifosine Akt Inhibitor SR13668 Akt Inhibitor MK2206 Akt Inhibitor LY2780301</Note><Position>23.0</Position></Entry><Entry><Code>MTOR i</Code><ShortDescription>MTOR inhibitor</ShortDescription><Description>DCLA-000020</Description><Synonyms/><Note>Everolimus Tacrolimus Zotarolimus Temsirolimus Sirolimus</Note><Position>24.0</Position></Entry><Entry><Code>MTORC1 i</Code><ShortDescription>MTORC1 inhibitor</ShortDescription><Description>DCLA-000021</Description><Synonyms/><Note>Ridaforolimus Sirolimus</Note><Position>25.0</Position></Entry><Entry><Code>MTORC1_aMs</Code><ShortDescription>MTORC1/MTORC2 inhibitor</ShortDescription><Description>DCLA-000023</Description><Synonyms/><Note/><Position>26.0</Position></Entry><Entry><Code>MTORC2 i</Code><ShortDescription>MTORC2 inhibitor</ShortDescription><Description>DCLA-000022</Description><Synonyms/><Note/><Position>27.0</Position></Entry><Entry><Code>PI3K a_uQZ</Code><ShortDescription>PI3K alpha inhibitor</ShortDescription><Description>DCLA-000183</Description><Synonyms/><Note>Inavolisib Alpelisib Buparlisib Copanlisib Pictilisib Taselisib Serabelisib</Note><Position>28.0</Position></Entry><Entry><Code>PI3K d_KRj</Code><ShortDescription>PI3K delta inhibitor</ShortDescription><Description>DCLA-000184</Description><Synonyms/><Note>Copanlisib Duvelisib Idelalisib Pictilisib Umbralisib Dezapelisib Tenalisib Parsaclisib</Note><Position>29.0</Position></Entry><Entry><Code>PI3K g_jqb</Code><ShortDescription>PI3K gamma inhibitor</ShortDescription><Description>DCLA-000185</Description><Synonyms/><Note>Duvelisib Tenalisib</Note><Position>30.0</Position></Entry><Entry><Code>PI3K i</Code><ShortDescription>PI3K inhibitor</ShortDescription><Description>DCLA-000186</Description><Synonyms/><Note/><Position>31.0</Position></Entry><Entry><Code>PI3K/A_+zE</Code><ShortDescription>PI3K/AKT/MTOR inhibitor</ShortDescription><Description>DCLA-000004</Description><Synonyms/><Note/><Position>32.0</Position></Entry><Entry><Code>TSC1 i</Code><ShortDescription>TSC1 inhibitor</ShortDescription><Description>DCLA-000218</Description><Synonyms/><Note/><Position>33.0</Position></Entry><Entry><Code>TSC2 i</Code><ShortDescription>TSC2 inhibitor</ShortDescription><Description>DCLA-000219</Description><Synonyms/><Note/><Position>34.0</Position></Entry><Entry><Code>ALK i</Code><ShortDescription>ALK inhibitor</ShortDescription><Description>DCLA-000009</Description><Synonyms/><Note>ALK Inhibitor ASP3026 ALK Inhibitor PLB 1003 ALK Inhibitor TAE684 Iruplinalkib Alectinib Crizotinib</Note><Position>35.0</Position></Entry><Entry><Code>EGFR ab</Code><ShortDescription>EGFR antibody</ShortDescription><Description>DCLA-000058</Description><Synonyms/><Note>Cetuximab Necitumumab Panitumumab Amivantamab Modotuximab Futuximab Imgatuzumab Anti-EGFR Monoclonal Antibody SYN004</Note><Position>36.0</Position></Entry><Entry><Code>EGFR/E_rLR</Code><ShortDescription>EGFR/ERBB3 antibody</ShortDescription><Description>DCLA-000253</Description><Synonyms/><Note>Duligotuzumab</Note><Position>37.0</Position></Entry><Entry><Code>EGFR/E_IR2</Code><ShortDescription>EGFR/ERBB2 inhibitor</ShortDescription><Description>DCLA-000359</Description><Synonyms/><Note>Sunvozertinib</Note><Position>38.0</Position></Entry><Entry><Code>ERBB2/_LV9</Code><ShortDescription>ERBB2/ERBB3 antibody</ShortDescription><Description>DCLA-000258</Description><Synonyms/><Note>Duligotuzumab Zenocutuzumab</Note><Position>39.0</Position></Entry><Entry><Code>ERBB3 ab</Code><ShortDescription>ERBB3 antibody</ShortDescription><Description>DCLA-000263</Description><Synonyms/><Note>Patritumab Seribantumab</Note><Position>40.0</Position></Entry><Entry><Code>FGFR2b ab</Code><ShortDescription>FGFR2b antibody</ShortDescription><Description>DCLA-000240</Description><Synonyms/><Note>Bemarituzumab</Note><Position>41.0</Position></Entry><Entry><Code>FGFR3 ab</Code><ShortDescription>FGFR3 antibody</ShortDescription><Description>DCLA-000256</Description><Synonyms/><Note>Vofatamab</Note><Position>42.0</Position></Entry><Entry><Code>HER2 ab</Code><ShortDescription>HER2 antibody</ShortDescription><Description>DCLA-000064</Description><Synonyms/><Note>Trastuzumab Duocarmazine Pertuzumab Trastuzumab</Note><Position>43.0</Position></Entry><Entry><Code>HGF ab</Code><ShortDescription>HGF antibody</ShortDescription><Description>DCLA-000065</Description><Synonyms/><Note>Rilotumumab</Note><Position>44.0</Position></Entry><Entry><Code>IGF-1R ab</Code><ShortDescription>IGF-1R antibody</ShortDescription><Description>DCLA-000067</Description><Synonyms/><Note>Cixutumumab Ganitumab Figitumumab Robatumumab Dalotuzumab</Note><Position>45.0</Position></Entry><Entry><Code>Met ab</Code><ShortDescription>Met antibody</ShortDescription><Description>DCLA-000040</Description><Synonyms/><Note>Onartuzumab Amivantamab Telisotuzumab Anti-Met Monoclonal Antibody Mixture Sym015 Emibetuzumab</Note><Position>46.0</Position></Entry><Entry><Code>PDGFRA ab</Code><ShortDescription>PDGFRA antibody</ShortDescription><Description>DCLA-000081</Description><Synonyms/><Note>Olaratumab Avapritinib</Note><Position>47.0</Position></Entry><Entry><Code>VEGF ab</Code><ShortDescription>VEGF antibody</ShortDescription><Description>DCLA-000088</Description><Synonyms/><Note>Bevacizumab Ranibizumab</Note><Position>48.0</Position></Entry><Entry><Code>AXL i</Code><ShortDescription>AXL inhibitor</ShortDescription><Description>DCLA-000107</Description><Synonyms/><Note>Cabozantinib Gilteritinib Mipasetamab Uzoptirine Bemcentinib Dubermatinib</Note><Position>49.0</Position></Entry><Entry><Code>BCR-ABL i</Code><ShortDescription>BCR-ABL inhibitor</ShortDescription><Description>DCLA-000109</Description><Synonyms/><Note>Radotinib Bosutinib Dasatinib Imatinib Nilotinib Ponatinib</Note><Position>50.0</Position></Entry><Entry><Code>BTK i</Code><ShortDescription>BTK inhibitor</ShortDescription><Description>DCLA-000112</Description><Synonyms/><Note>Acalabrutinib Dasatinib Ibrutinib Spebrutinib Fenebrutinib Vecabrutinib Tirabrutinib M7583 DTRMWXHS-12 Nemtabrutinib Poseltinib Zanubrutinib Pirtobrutinib JNJ-64264681</Note><Position>51.0</Position></Entry><Entry><Code>CSF1R i</Code><ShortDescription>CSF1R inhibitor</ShortDescription><Description>DCLA-000120</Description><Synonyms/><Note>Sunitinib Dovitinib Nilotinib CSF1R Inhibitor ABSK021 Edicotinib Emactuzumab Vimseltinib</Note><Position>52.0</Position></Entry><Entry><Code>DDR i</Code><ShortDescription>DDR inhibitor</ShortDescription><Description>DCLA-000122</Description><Synonyms/><Note>Nilotinib</Note><Position>53.0</Position></Entry><Entry><Code>EGFR i</Code><ShortDescription>EGFR inhibitor</ShortDescription><Description>DCLA-000031</Description><Synonyms/><Note>Afatinib Brigatinib Dacomitinib Erlotinib Gefitinib Ibrutinib Icotinib Lapatinib Neratinib Rociletinib Vandetanib Pyrotinib Mobocertinib Zorifertinib Lifirafenib</Note><Position>54.0</Position></Entry><Entry><Code>EGFR T_3pi</Code><ShortDescription>EGFR T790M inhibitor</ShortDescription><Description>DCLA-000032</Description><Synonyms/><Note>Osimertinib</Note><Position>55.0</Position></Entry><Entry><Code>ERBB2 i</Code><ShortDescription>ERBB2 inhibitor</ShortDescription><Description>DCLA-000132</Description><Synonyms/><Note>Afatinib Lapatinib Neratinib Tucatinib Pyrotinib</Note><Position>56.0</Position></Entry><Entry><Code>ERBB3 i</Code><ShortDescription>ERBB3 inhibitor</ShortDescription><Description>DCLA-000133</Description><Synonyms/><Note>Neratinib</Note><Position>57.0</Position></Entry><Entry><Code>ERBB4 i</Code><ShortDescription>ERBB4 inhibitor</ShortDescription><Description>DCLA-000134</Description><Synonyms/><Note>Afatinib Neratinib</Note><Position>58.0</Position></Entry><Entry><Code>FGFR i</Code><ShortDescription>FGFR inhibitor</ShortDescription><Description>DCLA-000026</Description><Synonyms/><Note>Pazopanib Masitinib Dovitinib Erdafitinib Infigratinib Lenvatinib Nintedanib Ponatinib Regorafenib Orantinib</Note><Position>59.0</Position></Entry><Entry><Code>FGFR1 i</Code><ShortDescription>FGFR1 inhibitor</ShortDescription><Description>DCLA-000025</Description><Synonyms/><Note/><Position>60.0</Position></Entry><Entry><Code>FGFR2 i</Code><ShortDescription>FGFR2 inhibitor</ShortDescription><Description>DCLA-000027</Description><Synonyms/><Note/><Position>61.0</Position></Entry><Entry><Code>FGFR3 i</Code><ShortDescription>FGFR3 inhibitor</ShortDescription><Description>DCLA-000028</Description><Synonyms/><Note/><Position>62.0</Position></Entry><Entry><Code>FGFR4 i</Code><ShortDescription>FGFR4 inhibitor</ShortDescription><Description>DCLA-000029</Description><Synonyms/><Note/><Position>63.0</Position></Entry><Entry><Code>FLT3 i</Code><ShortDescription>FLT3 inhibitor</ShortDescription><Description>DCLA-000138</Description><Synonyms/><Note>Sunitinib Crenolanib Brigatinib Cabozantinib Dovitinib Gilteritinib Lestaurtinib Midostaurin Pacritinib Ponatinib Quizartinib Sorafenib Tandutinib</Note><Position>64.0</Position></Entry><Entry><Code>IGF-1R i</Code><ShortDescription>IGF-1R inhibitor</ShortDescription><Description>DCLA-000262</Description><Synonyms/><Note>Linsitinib</Note><Position>65.0</Position></Entry><Entry><Code>IGFR i</Code><ShortDescription>IGFR inhibitor</ShortDescription><Description>DCLA-000157</Description><Synonyms/><Note>Brigatinib Ceritinib</Note><Position>66.0</Position></Entry><Entry><Code>ITK i</Code><ShortDescription>ITK inhibitor</ShortDescription><Description>DCLA-000160</Description><Synonyms/><Note>Ibrutinib</Note><Position>67.0</Position></Entry><Entry><Code>JAK1 i</Code><ShortDescription>JAK1 inhibitor</ShortDescription><Description>DCLA-000255</Description><Synonyms/><Note>Itacitinib</Note><Position>68.0</Position></Entry><Entry><Code>JAK1/J_tNN</Code><ShortDescription>JAK1/JAK2 inhibitor</ShortDescription><Description>DCLA-000161</Description><Synonyms/><Note>Tofacitinib Lestaurtinib Momelotinib Ruxolitinib Cerdulatinib Baricitinib</Note><Position>69.0</Position></Entry><Entry><Code>JAK2 i</Code><ShortDescription>JAK2 inhibitor</ShortDescription><Description>DCLA-000254</Description><Synonyms/><Note>Fedratinib Pacritinib Gandotinib</Note><Position>70.0</Position></Entry><Entry><Code>JAK3 i</Code><ShortDescription>JAK3 inhibitor</ShortDescription><Description>DCLA-000259</Description><Synonyms/><Note>Ritlecitinib</Note><Position>71.0</Position></Entry><Entry><Code>KIT i</Code><ShortDescription>KIT inhibitor</ShortDescription><Description>DCLA-000033</Description><Synonyms/><Note>Sunitinib Pazopanib Masitinib Motesanib Axitinib Cabozantinib Dasatinib Dovitinib Imatinib Lenvatinib Midostaurin Nilotinib Ponatinib Regorafenib Sorafenib Semaxanib Vatalanib Orantinib Tandutinib Avapritinib</Note><Position>72.0</Position></Entry><Entry><Code>KSP i</Code><ShortDescription>KSP inhibitor</ShortDescription><Description>DCLA-000162</Description><Synonyms/><Note>Filanesib</Note><Position>73.0</Position></Entry><Entry><Code>MET i</Code><ShortDescription>MET inhibitor</ShortDescription><Description>DCLA-000010</Description><Synonyms/><Note>Cabozantinib Capmatinib Crizotinib Lenvatinib Tivantinib Foretinib Golvatinib MET Tyrosine Kinase Inhibitor SAR125844 AMG 337 c-Met Inhibitor AMG 208 Tepotinib MET Tyrosine Kinase Inhibitor PF-04217903 MET Tyrosine Kinase Inhibitor EMD 1204831 Merestinib</Note><Position>74.0</Position></Entry><Entry><Code>MET i _mwd</Code><ShortDescription>MET inhibitor (for exon 14 skipping mutation)</ShortDescription><Description>DCLA-000011</Description><Synonyms/><Note>Capmatinib</Note><Position>75.0</Position></Entry><Entry><Code>Multi _Dz4</Code><ShortDescription>Multi kinase inhibitor</ShortDescription><Description>DCLA-000001</Description><Synonyms/><Note>Sunitinib Pazopanib Axitinib Dasatinib Amuvatinib Sulfatinib</Note><Position>76.0</Position></Entry><Entry><Code>NTRK i</Code><ShortDescription>NTRK inhibitor</ShortDescription><Description>DCLA-000003</Description><Synonyms/><Note>Repotrectinib Crizotinib Entrectinib Larotrectinib Selitrectinib</Note><Position>77.0</Position></Entry><Entry><Code>panERBB i</Code><ShortDescription>panERBB inhibitor</ShortDescription><Description>DCLA-000017</Description><Synonyms/><Note>Afatinib Lapatinib Pyrotinib Pirotinib Pelitinib Varlitinib Tesevatinib Poziotinib</Note><Position>78.0</Position></Entry><Entry><Code>panFGFR i</Code><ShortDescription>panFGFR inhibitor</ShortDescription><Description>DCLA-000030</Description><Synonyms/><Note>Derazantinib Erdafitinib Futibatinib Infigratinib Pemigatinib Rogaratinib</Note><Position>79.0</Position></Entry><Entry><Code>panPDGFR i</Code><ShortDescription>panPDGFR inhibitor</ShortDescription><Description>DCLA-000179</Description><Synonyms/><Note>Sunitinib Pazopanib Crenolanib Masitinib Motesanib Radotinib Axitinib Dasatinib Dovitinib Imatinib Lenvatinib Midostaurin Nilotinib Nintedanib Ponatinib Regorafenib Sorafenib Vandetanib Vatalanib Orantinib Tandutinib</Note><Position>80.0</Position></Entry><Entry><Code>PTK2 i</Code><ShortDescription>PTK2 inhibitor</ShortDescription><Description>DCLA-000192</Description><Synonyms/><Note>Masitinib</Note><Position>81.0</Position></Entry><Entry><Code>RAF1 i</Code><ShortDescription>RAF1 inhibitor</ShortDescription><Description>DCLA-000199</Description><Synonyms/><Note>Sorafenib Vemurafenib Avutometinib</Note><Position>82.0</Position></Entry><Entry><Code>RET i</Code><ShortDescription>RET inhibitor</ShortDescription><Description>DCLA-000002</Description><Synonyms/><Note>Cabozantinib Lenvatinib Selpercatinib Pralsetinib</Note><Position>83.0</Position></Entry><Entry><Code>ROS1 i</Code><ShortDescription>ROS1 inhibitor</ShortDescription><Description>DCLA-000201</Description><Synonyms/><Note>Brigatinib Cabozantinib Ceritinib Crizotinib Ensartinib Entrectinib Lorlatinib</Note><Position>84.0</Position></Entry><Entry><Code>SRC i</Code><ShortDescription>SRC inhibitor</ShortDescription><Description>DCLA-000206</Description><Synonyms/><Note>Pazopanib Bosutinib Dasatinib Nintedanib Ponatinib Vandetanib</Note><Position>85.0</Position></Entry><Entry><Code>SYK i</Code><ShortDescription>SYK inhibitor</ShortDescription><Description>DCLA-000210</Description><Synonyms/><Note>Fostamatinib Dasatinib Entospletinib Mivavotinib</Note><Position>86.0</Position></Entry><Entry><Code>TEC i</Code><ShortDescription>TEC inhibitor</ShortDescription><Description>DCLA-000212</Description><Synonyms/><Note>Ibrutinib</Note><Position>87.0</Position></Entry><Entry><Code>TEK i</Code><ShortDescription>TEK inhibitor</ShortDescription><Description>DCLA-000213</Description><Synonyms/><Note>Cabozantinib Regorafenib Vandetanib</Note><Position>88.0</Position></Entry><Entry><Code>TXK i</Code><ShortDescription>TXK inhibitor</ShortDescription><Description>DCLA-000224</Description><Synonyms/><Note>Ibrutinib</Note><Position>89.0</Position></Entry><Entry><Code>VEGFR i</Code><ShortDescription>VEGFR inhibitor</ShortDescription><Description>DCLA-000227</Description><Synonyms/><Note>Sunitinib Pazopanib Motesanib Axitinib Cabozantinib Cediranib Dovitinib Fruquintinib Lenvatinib Nintedanib Ponatinib Ramucirumab Regorafenib Sorafenib Tivozanib Vandetanib Rivoceranib Semaxanib Vatalanib Orantinib</Note><Position>90.0</Position></Entry><Entry><Code>BRAF i</Code><ShortDescription>BRAF inhibitor</ShortDescription><Description>DCLA-000018</Description><Synonyms/><Note>Regorafenib Sorafenib Naporafenib Lifirafenib Belvarafenib</Note><Position>91.0</Position></Entry><Entry><Code>BRAF V_DlW</Code><ShortDescription>BRAF V600E inhibitor</ShortDescription><Description>DCLA-000019</Description><Synonyms/><Note>Dabrafenib Encorafenib Vemurafenib Belvarafenib</Note><Position>92.0</Position></Entry><Entry><Code>Farnes_/4N</Code><ShortDescription>Farnesyltransferase inhibitor</ShortDescription><Description>DCLA-000137</Description><Synonyms/><Note>Tipifarnib Lonafarnib</Note><Position>93.0</Position></Entry><Entry><Code>KRAS G_bEF</Code><ShortDescription>KRAS G12C inhibitor</ShortDescription><Description>DCLA-000015</Description><Synonyms/><Note>Adagrasib Sotorasib KRAS G12C Inhibitor GFH925 KRAS G12C Inhibitor LY3499446 KRASG12C Inhibitor JNJ-74699157 KRAS G12C Inhibitor GDC-6036 KRAS G12C Inhibitor JDQ443 KRAS G12C Inhibitor D-1553 KRAS-G12C Inhibitor LY3537982 KRAS G12C Inhibitor JAB-21822 BI 1823911</Note><Position>94.0</Position></Entry><Entry><Code>KRAS G_NFM</Code><ShortDescription>KRAS G12D inhibitor</ShortDescription><Description>DCLA-000361</Description><Synonyms/><Note>MRTX1133</Note><Position>95.0</Position></Entry><Entry><Code>KRAS m_0k2</Code><ShortDescription>KRAS mimetic inhibitor</ShortDescription><Description>DCLA-000257</Description><Synonyms/><Note>Rigosertib</Note><Position>96.0</Position></Entry><Entry><Code>MAP2K1 i</Code><ShortDescription>MAP2K1 inhibitor</ShortDescription><Description>DCLA-000163</Description><Synonyms/><Note>Binimetinib Cobimetinib Refametinib Selumetinib Trametinib</Note><Position>97.0</Position></Entry><Entry><Code>MAP2K2 i</Code><ShortDescription>MAP2K2 inhibitor</ShortDescription><Description>DCLA-000164</Description><Synonyms/><Note>Binimetinib Cobimetinib Selumetinib Trametinib</Note><Position>98.0</Position></Entry><Entry><Code>MAP2K4 i</Code><ShortDescription>MAP2K4 inhibitor</ShortDescription><Description>DCLA-000165</Description><Synonyms/><Note>Vemurafenib</Note><Position>99.0</Position></Entry><Entry><Code>MAP3K20 i</Code><ShortDescription>MAP3K20 inhibitor</ShortDescription><Description>DCLA-000166</Description><Synonyms/><Note>Vemurafenib</Note><Position>100.0</Position></Entry><Entry><Code>MAP4K5 i</Code><ShortDescription>MAP4K5 inhibitor</ShortDescription><Description>DCLA-000167</Description><Synonyms/><Note>Vemurafenib</Note><Position>101.0</Position></Entry><Entry><Code>MEK i</Code><ShortDescription>MEK inhibitor</ShortDescription><Description>DCLA-000014</Description><Synonyms/><Note>Binimetinib Cobimetinib Selumetinib Trametinib Avutometinib</Note><Position>102.0</Position></Entry><Entry><Code>panRAF i</Code><ShortDescription>panRAF inhibitor</ShortDescription><Description>DCLA-000016</Description><Synonyms/><Note>Regorafenib Sorafenib Naporafenib Belvarafenib</Note><Position>103.0</Position></Entry><Entry><Code>SHP2 i</Code><ShortDescription>SHP2 inhibitor</ShortDescription><Description>DCLA-000267</Description><Synonyms/><Note>TNO155 RMC-4630 RLY-1971 ERAS-601 BBP-398 PF-07284892 JAB-3068 SH3809 HBI-2376 HS-10381</Note><Position>104.0</Position></Entry><Entry><Code>ATR i</Code><ShortDescription>ATR inhibitor</ShortDescription><Description>DCLA-000176</Description><Synonyms/><Note>Berzosertib Camonsertib</Note><Position>105.0</Position></Entry><Entry><Code>KIF18A_X8F</Code><ShortDescription>KIF18A Inhibitor</ShortDescription><Description>DCLA-000249</Description><Synonyms/><Note>AMG 650</Note><Position>106.0</Position></Entry><Entry><Code>PARP i</Code><ShortDescription>PARP inhibitor</ShortDescription><Description>DCLA-000175</Description><Synonyms/><Note>Niraparib Olaparib Rucaparib Talazoparib Veliparib Venadaparib</Note><Position>107.0</Position></Entry><Entry><Code>NOTCH1 ab</Code><ShortDescription>NOTCH1 antibody</ShortDescription><Description>DCLA-000251</Description><Synonyms/><Note>Brontictuzumab</Note><Position>108.0</Position></Entry><Entry><Code>NOTCH2_kgs</Code><ShortDescription>NOTCH2/NOTCH3 antibody</ShortDescription><Description>DCLA-000252</Description><Synonyms/><Note>Tarextumab</Note><Position>109.0</Position></Entry><Entry><Code>panNotch i</Code><ShortDescription>panNotch inhibitor</ShortDescription><Description>DCLA-000273</Description><Synonyms/><Note>CB-103</Note><Position>110.0</Position></Entry><Entry><Code>Hedgeh_kWU</Code><ShortDescription>Hedgehog pathway inhibitor</ShortDescription><Description>DCLA-000148</Description><Synonyms/><Note>Glasdegib Sonidegib Vismodegib</Note><Position>111.0</Position></Entry><Entry><Code>SMO i</Code><ShortDescription>SMO inhibitor</ShortDescription><Description>DCLA-000204</Description><Synonyms/><Note>Sonidegib Vismodegib Taladegib</Note><Position>112.0</Position></Entry><Entry><Code>TBL1 i</Code><ShortDescription>TBL1 inhibitor</ShortDescription><Description>DCLA-000265</Description><Synonyms/><Note>Tegavivint</Note><Position>113.0</Position></Entry><Entry><Code>Porcup_PEN</Code><ShortDescription>Porcupine inhibitor</ShortDescription><Description>DCLA-000271</Description><Synonyms/><Note>WNT974 RXC004 ETC-1922159 CGX1321 XNW7201 Wnt-C59</Note><Position>114.0</Position></Entry><Entry><Code>YAP1/T_R3n</Code><ShortDescription>YAP1/TEAD interaction inhibitor</ShortDescription><Description>DCLA-000266</Description><Synonyms/><Note>YAP/TEAD Interaction Inhibitor IAG933</Note><Position>115.0</Position></Entry><Entry><Code>A2AR i</Code><ShortDescription>A2AR inhibitor</ShortDescription><Description>DCLA-000286</Description><Synonyms/><Note>Taminadenant Ciforadenant Adenosine A2A Receptor Antagonist NIR178 Imaradenant Adenosine A2B Receptor Antagonist PBF-1129 Etrumadenant Inupadenant A2A/A2B Adenosine Receptor Antagonist INCB106385 Adenosine A2A Receptor Antagonist DZD2269 EXS21546 TT-10</Note><Position>116.0</Position></Entry><Entry><Code>Checkp_ZL7</Code><ShortDescription>Checkpoint inhibitor</ShortDescription><Description>DCLA-000024</Description><Synonyms/><Note>Tiragolumab</Note><Position>117.0</Position></Entry><Entry><Code>B7-H3 ab</Code><ShortDescription>B7-H3 antibody</ShortDescription><Description>DCLA-000222</Description><Synonyms/><Note>Enoblituzumab</Note><Position>118.0</Position></Entry><Entry><Code>CCR4 ab</Code><ShortDescription>CCR4 antibody</ShortDescription><Description>DCLA-000042</Description><Synonyms/><Note>Mogamulizumab</Note><Position>119.0</Position></Entry><Entry><Code>CD47 ab</Code><ShortDescription>CD47 antibody</ShortDescription><Description>DCLA-000237</Description><Synonyms/><Note>Magrolimab</Note><Position>120.0</Position></Entry><Entry><Code>CD47/M_xbg</Code><ShortDescription>CD47/MSLN antibody</ShortDescription><Description>DCLA-000268</Description><Synonyms/><Note>NI-1801</Note><Position>121.0</Position></Entry><Entry><Code>CD73 ab</Code><ShortDescription>CD73 antibody</ShortDescription><Description>DCLA-000234</Description><Synonyms/><Note>Oleclumab Uliledlimab BMS-986179 Mupadolimab NZV930 Sym024 Dresbuxelimab INCA00186 IBI325 JAB-BX102</Note><Position>122.0</Position></Entry><Entry><Code>CD73 i</Code><ShortDescription>CD73 inhibitor</ShortDescription><Description>DCLA-000348</Description><Synonyms/><Note>Quemliclustat LY3475070 HLX23 ORIC-533</Note><Position>123.0</Position></Entry><Entry><Code>CTLA4 ab</Code><ShortDescription>CTLA4 antibody</ShortDescription><Description>DCLA-000055</Description><Synonyms/><Note>Ipilimumab Tremelimumab Zalifrelimab</Note><Position>124.0</Position></Entry><Entry><Code>LAG3 ab</Code><ShortDescription>LAG3 antibody</ShortDescription><Description>DCLA-000006</Description><Synonyms/><Note>Tebotelimab Fianlimab Miptenalimab</Note><Position>125.0</Position></Entry><Entry><Code>PD-1 ab</Code><ShortDescription>PD-1 antibody</ShortDescription><Description>DCLA-000079</Description><Synonyms/><Note>Nivolumab Pembrolizumab Retifanlimab Cemiplimab Pidilizumab Zeluvalimab Tislelizumab Cetrelimab Toripalimab Ezabenlimab Sintilimab Balstilimab Pimivalimab Zimberelimab</Note><Position>126.0</Position></Entry><Entry><Code>PD-L1 ab</Code><ShortDescription>PD-L1 antibody</ShortDescription><Description>DCLA-000080</Description><Synonyms/><Note>Atezolizumab Avelumab Durvalumab Envafolimab Cosibelimab Sugemalimab Spartalizumab Anti-PD-L1 Monoclonal Antibody Anti-PD-L1 Monoclonal Antibody FAZ053 Anti-PD-L1 Monoclonal Antibody MDX-1105 Danburstotug Opucolimab Tagitanlimab Socazolimab PD-L1 Inhibitor INCB086550 Betifisolimab Garivulimab Lodapolimab AN4005</Note><Position>127.0</Position></Entry><Entry><Code>PD-L1/_kCM</Code><ShortDescription>PD-L1/CD137 antibody</ShortDescription><Description>DCLA-000278</Description><Synonyms/><Note>Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105 Anti-PD-L1/CD137 Bispecific Antibody MCLA-145 Acasunlimab</Note><Position>128.0</Position></Entry><Entry><Code>PD-L1/_Pp1</Code><ShortDescription>PD-L1/CD137/HSA antibody</ShortDescription><Description>DCLA-000279</Description><Synonyms/><Note>PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480</Note><Position>129.0</Position></Entry><Entry><Code>PD-L1/_LlH</Code><ShortDescription>PD-L1/TGF-Beta antibody</ShortDescription><Description>DCLA-000235</Description><Synonyms/><Note>Anti-PD-L1/TGF-beta Bispecific Antibody Y101D</Note><Position>130.0</Position></Entry><Entry><Code>PD-L1/_bgG</Code><ShortDescription>PD-L1/TIM-3 antibody</ShortDescription><Description>DCLA-000277</Description><Synonyms/><Note>Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244</Note><Position>131.0</Position></Entry><Entry><Code>PD-L1 _OYR</Code><ShortDescription>PD-L1 radioimmunoconjugate</ShortDescription><Description>DCLA-000276</Description><Synonyms/><Note>Zirconium Zr 89-labeled Atezolizumab Fluorine F 18-BMS-986229</Note><Position>132.0</Position></Entry><Entry><Code>TIGIT ab</Code><ShortDescription>TIGIT antibody</ShortDescription><Description>DCLA-000238</Description><Synonyms/><Note>Domvanalimab</Note><Position>133.0</Position></Entry><Entry><Code>TLR9 a_3EU</Code><ShortDescription>TLR9 agonist</ShortDescription><Description>DCLA-000236</Description><Synonyms/><Note>Pixatimod</Note><Position>134.0</Position></Entry><Entry><Code>IFNg ab</Code><ShortDescription>IFNg antibody</ShortDescription><Description>DCLA-000066</Description><Synonyms/><Note>Emapalumab</Note><Position>135.0</Position></Entry><Entry><Code>IL-5 ab</Code><ShortDescription>IL-5 antibody</ShortDescription><Description>DCLA-000068</Description><Synonyms/><Note>Benralizumab Mepolizumab</Note><Position>136.0</Position></Entry><Entry><Code>IL-6 ab</Code><ShortDescription>IL-6 antibody</ShortDescription><Description>DCLA-000069</Description><Synonyms/><Note>Siltuximab</Note><Position>137.0</Position></Entry><Entry><Code>IL-6R ab</Code><ShortDescription>IL-6R antibody</ShortDescription><Description>DCLA-000070</Description><Synonyms/><Note>Tocilizumab</Note><Position>138.0</Position></Entry><Entry><Code>Interferon</Code><ShortDescription>Interferon</ShortDescription><Description>DCLA-000159</Description><Synonyms/><Note>Interferon Beta-1A Interferon Beta-1B Interferon Gamma-1a Interferon Gamma-1b Peginterferon Beta-1A Peginterferon Lambda-1A Recombinant Interferon Beta Recombinant Interferon Gamma</Note><Position>139.0</Position></Entry><Entry><Code>Dendri_QV0</Code><ShortDescription>Dendritic cell vaccine</ShortDescription><Description>DCLA-000123</Description><Synonyms/><Note>Sipuleucel-T IKKb-matured RNA-loaded Autologous Dendritic Cells DCIKKb</Note><Position>140.0</Position></Entry><Entry><Code>Oncoly_+pe</Code><ShortDescription>Oncolytic viral therapy</ShortDescription><Description>DCLA-000172</Description><Synonyms/><Note>Talimogene Laherparepvec</Note><Position>141.0</Position></Entry><Entry><Code>Tumor _Vhd</Code><ShortDescription>Tumor vaccine</ShortDescription><Description>DCLA-000220</Description><Synonyms/><Note>Belagenpumatucel-L</Note><Position>142.0</Position></Entry><Entry><Code>Telome_f5P</Code><ShortDescription>Telomerase vaccine</ShortDescription><Description>DCLA-000343</Description><Synonyms/><Note>UCPVax</Note><Position>143.0</Position></Entry><Entry><Code>Solubl_zyf</Code><ShortDescription>Soluble LAG3-3Ig</ShortDescription><Description>DCLA-000221</Description><Synonyms/><Note>Eftilagimod Alpha</Note><Position>144.0</Position></Entry><Entry><Code>MAGEA1_KC7</Code><ShortDescription>MAGEA1 eTCR therapy</ShortDescription><Description>DCLA-000275</Description><Synonyms/><Note>MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells Autologous TCR-engineered T-cells IMA202</Note><Position>145.0</Position></Entry><Entry><Code>MAGEA3_5aL</Code><ShortDescription>MAGEA3/A6 eTCR therapy</ShortDescription><Description>DCLA-000281</Description><Synonyms/><Note>Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718</Note><Position>146.0</Position></Entry><Entry><Code>MAGEA4_PqO</Code><ShortDescription>MAGEA4 eTCR therapy</ShortDescription><Description>DCLA-000280</Description><Synonyms/><Note>MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201</Note><Position>147.0</Position></Entry><Entry><Code>CLDN6 _GIw</Code><ShortDescription>CLDN6 CAR-T</ShortDescription><Description>DCLA-000345</Description><Synonyms/><Note>Anti-CLDN6 CAR T-cells</Note><Position>148.0</Position></Entry><Entry><Code>CLDN6/_YX3</Code><ShortDescription>CLDN6/CD3 antibody</ShortDescription><Description>DCLA-000347</Description><Synonyms/><Note>AMG794</Note><Position>149.0</Position></Entry><Entry><Code>MET CA_xe1</Code><ShortDescription>MET CAR-T therapy</ShortDescription><Description>DCLA-000282</Description><Synonyms/><Note>cMet CAR-mRNA Electroporated Autologous T Lymphocytes</Note><Position>150.0</Position></Entry><Entry><Code>CLDN6 ab</Code><ShortDescription>CLDN6 antibody</ShortDescription><Description>DCLA-000344</Description><Synonyms/><Note>ASP1650</Note><Position>151.0</Position></Entry><Entry><Code>CLDN6/_Di0</Code><ShortDescription>CLDN6/CD3 antibody mRNA</ShortDescription><Description>DCLA-000346</Description><Synonyms/><Note>BNT142</Note><Position>152.0</Position></Entry><Entry><Code>CD73/T_uJd</Code><ShortDescription>CD73/TGF Beta antibody</ShortDescription><Description>DCLA-000349</Description><Synonyms/><Note>Dalutrafusp Alfa</Note><Position>153.0</Position></Entry><Entry><Code>BCL2 i</Code><ShortDescription>BCL2 inhibitor</ShortDescription><Description>DCLA-000108</Description><Synonyms/><Note>Venetoclax Navitoclax</Note><Position>154.0</Position></Entry><Entry><Code>CDK i</Code><ShortDescription>CDK inhibitor</ShortDescription><Description>DCLA-000115</Description><Synonyms/><Note>Alvocidib Dinaciclib</Note><Position>155.0</Position></Entry><Entry><Code>CDK4/6 i</Code><ShortDescription>CDK4/6 inhibitor</ShortDescription><Description>DCLA-000007</Description><Synonyms/><Note>Abemaciclib Palbociclib Ribociclib Voruciclib</Note><Position>156.0</Position></Entry><Entry><Code>MDM2 i</Code><ShortDescription>MDM2 inhibitor</ShortDescription><Description>DCLA-000005</Description><Synonyms/><Note>p53-HDM2 Interaction Inhibitor MI-773 Siremadlin Milademetan Tosylate Navtemadlin HDM2 Inhibitor MK-8242 MDM2 Inhibitor BI 907828 MDM2 Antagonist ASTX295 Rebemadlin MDM2 Antagonist RO5045337 Idasanutlin</Note><Position>157.0</Position></Entry><Entry><Code>PLK1 i</Code><ShortDescription>PLK1 inhibitor</ShortDescription><Description>DCLA-000188</Description><Synonyms/><Note>Volasertib Onvansertib</Note><Position>158.0</Position></Entry><Entry><Code>TP53 a_FKn</Code><ShortDescription>TP53 activator</ShortDescription><Description>DCLA-000350</Description><Synonyms/><Note>Eprenetapopt</Note><Position>159.0</Position></Entry><Entry><Code>TP53 Y_3az</Code><ShortDescription>TP53 Y220C activator</ShortDescription><Description>DCLA-000351</Description><Synonyms/><Note>PC14586</Note><Position>160.0</Position></Entry><Entry><Code>WEE1 i</Code><ShortDescription>WEE1 inhibitor</ShortDescription><Description>DCLA-000189</Description><Synonyms/><Note>Adavosertib</Note><Position>161.0</Position></Entry><Entry><Code>Aurora_cpG</Code><ShortDescription>Aurora kinase A inhibitor</ShortDescription><Description>DCLA-000106</Description><Synonyms/><Note>Barasertib Alisertib</Note><Position>162.0</Position></Entry><Entry><Code>Aurora_R7/</Code><ShortDescription>Aurora kinase B inhibitor</ShortDescription><Description>DCLA-000152</Description><Synonyms/><Note/><Position>163.0</Position></Entry><Entry><Code>Aurora_R4P</Code><ShortDescription>Aurora kinase inhibitor</ShortDescription><Description>DCLA-000105</Description><Synonyms/><Note>Cenisertib</Note><Position>164.0</Position></Entry><Entry><Code>BET i</Code><ShortDescription>BET inhibitor</ShortDescription><Description>DCLA-000013</Description><Synonyms/><Note>Molibresib Birabresib</Note><Position>165.0</Position></Entry><Entry><Code>BRD4 i</Code><ShortDescription>BRD4 inhibitor</ShortDescription><Description>DCLA-000012</Description><Synonyms/><Note>Bivalent BRD4 Inhibitor AZD5153 BRD4 Inhibitor PLX2853 BRD4 Inhibitor PLX51107 Molibresib</Note><Position>166.0</Position></Entry><Entry><Code>Hsp90 i</Code><ShortDescription>Hsp90 inhibitor</ShortDescription><Description>DCLA-000151</Description><Synonyms/><Note>Ganetespib Retaspimycin</Note><Position>167.0</Position></Entry><Entry><Code>IDH i</Code><ShortDescription>IDH inhibitor</ShortDescription><Description>DCLA-000153</Description><Synonyms/><Note/><Position>168.0</Position></Entry><Entry><Code>IDH1 i</Code><ShortDescription>IDH1 inhibitor</ShortDescription><Description>DCLA-000155</Description><Synonyms/><Note>Ivosidenib</Note><Position>169.0</Position></Entry><Entry><Code>IDH2 i</Code><ShortDescription>IDH2 inhibitor</ShortDescription><Description>DCLA-000156</Description><Synonyms/><Note>Enasidenib</Note><Position>170.0</Position></Entry><Entry><Code>MCL1 i</Code><ShortDescription>MCL1 inhibitor</ShortDescription><Description>DCLA-000243</Description><Synonyms/><Note>Tapotoclax</Note><Position>171.0</Position></Entry><Entry><Code>PRMT5 i</Code><ShortDescription>PRMT5 inhibitor</ShortDescription><Description>DCLA-000244</Description><Synonyms/><Note>AMG 193</Note><Position>172.0</Position></Entry><Entry><Code>DNA me_geT</Code><ShortDescription>DNA methyltransferase inhibitor</ShortDescription><Description>DCLA-000128</Description><Synonyms/><Note>Guadecitabine Azacitidine Decitabine</Note><Position>173.0</Position></Entry><Entry><Code>EZH2 i</Code><ShortDescription>EZH2 inhibitor</ShortDescription><Description>DCLA-000147</Description><Synonyms/><Note>Tazemetostat</Note><Position>174.0</Position></Entry><Entry><Code>HDAC i</Code><ShortDescription>HDAC inhibitor</ShortDescription><Description>DCLA-000146</Description><Synonyms/><Note>Abexinostat Belinostat Entinostat Mocetinostat Panobinostat Pracinostat Quisinostat Ricolinostat Romidepsin Vorinostat</Note><Position>175.0</Position></Entry><Entry><Code>Autoph_BhF</Code><ShortDescription>Autophagy inhibitor</ShortDescription><Description>DCLA-000191</Description><Synonyms/><Note>Hydroxychloroquine Chloroquine Mefloquine</Note><Position>176.0</Position></Entry><Entry><Code>Protea_BcS</Code><ShortDescription>Proteasome inhibitor</ShortDescription><Description>DCLA-000190</Description><Synonyms/><Note>Bortezomib Carfilzomib Ixazomib Oprozomib</Note><Position>177.0</Position></Entry><Entry><Code>CD20 ab</Code><ShortDescription>CD20 antibody</ShortDescription><Description>DCLA-000045</Description><Synonyms/><Note>Ublituximab Obinutuzumab Ofatumumab Rituximab Veltuzumab</Note><Position>178.0</Position></Entry><Entry><Code>CD38 ab</Code><ShortDescription>CD38 antibody</ShortDescription><Description>DCLA-000052</Description><Synonyms/><Note>Daratumumab Isatuximab Mezagitamab</Note><Position>179.0</Position></Entry><Entry><Code>CD52 ab</Code><ShortDescription>CD52 antibody</ShortDescription><Description>DCLA-000053</Description><Synonyms/><Note>Alemtuzumab</Note><Position>180.0</Position></Entry><Entry><Code>CLDN18_D4K</Code><ShortDescription>CLDN18.2 antibody</ShortDescription><Description>DCLA-000250</Description><Synonyms/><Note>Zolbetuximab AB011 Osemitamab ASKB589 MIL93 M108 LM-102 NBL-015</Note><Position>181.0</Position></Entry><Entry><Code>DLL4 ab</Code><ShortDescription>DLL4 antibody</ShortDescription><Description>DCLA-000264</Description><Synonyms/><Note>Demcizumab Enoticumab</Note><Position>182.0</Position></Entry><Entry><Code>FOLR1 ab</Code><ShortDescription>FOLR1 antibody</ShortDescription><Description>DCLA-000261</Description><Synonyms/><Note>Farletuzumab</Note><Position>183.0</Position></Entry><Entry><Code>mesoth_uaC</Code><ShortDescription>mesothelin antibody</ShortDescription><Description>DCLA-000072</Description><Synonyms/><Note>Amatuximab Mesothelin-specific Chimeric Antigen Receptor-engineered Peripheral Blood Lymphocytes</Note><Position>184.0</Position></Entry><Entry><Code>MUC16 ab</Code><ShortDescription>MUC16 antibody</ShortDescription><Description>DCLA-000260</Description><Synonyms/><Note>Abagovomab</Note><Position>185.0</Position></Entry><Entry><Code>SLAMF7 ab</Code><ShortDescription>SLAMF7 antibody</ShortDescription><Description>DCLA-000084</Description><Synonyms/><Note>Elotuzumab</Note><Position>186.0</Position></Entry><Entry><Code>STEAP1_Vl0</Code><ShortDescription>STEAP1/CD3 bispecific antibody</ShortDescription><Description>DCLA-000248</Description><Synonyms/><Note>AMG 509</Note><Position>187.0</Position></Entry><Entry><Code>Antith_y6u</Code><ShortDescription>Antithymocyte globulin</ShortDescription><Description>DCLA-000101</Description><Synonyms/><Note>Equine Thymocyte Immune Globulin</Note><Position>188.0</Position></Entry><Entry><Code>PRAME _CDm</Code><ShortDescription>PRAME eTCR T-cells</ShortDescription><Description>DCLA-000287</Description><Synonyms/><Note>Autologous TCR-engineered T-cells IMA203 Patient-derived WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes WT1/PRAME/Survivin-specific T-cells MANA-312</Note><Position>189.0</Position></Entry><Entry><Code>Surviv_BwE</Code><ShortDescription>Survivin eTCR T-cells</ShortDescription><Description>DCLA-000289</Description><Synonyms/><Note>Patient-derived WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes WT1/PRAME/Survivin-specific T-cells MANA-312</Note><Position>190.0</Position></Entry><Entry><Code>WT1 eT_8lt</Code><ShortDescription>WT1 eTCR T-cells</ShortDescription><Description>DCLA-000288</Description><Synonyms/><Note>Patient-derived WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes WT1/PRAME/Survivin-specific Cytotoxic T-lymphocytes WT1/PRAME/Survivin-specific T-cells MANA-312</Note><Position>191.0</Position></Entry><Entry><Code>PMEL s_+dq</Code><ShortDescription>PMEL soluble bispecific eTCR</ShortDescription><Description>DCLA-000223</Description><Synonyms/><Note>Tebentafusp</Note><Position>192.0</Position></Entry><Entry><Code>PRAME _t3p</Code><ShortDescription>PRAME soluble bispecific eTCR</ShortDescription><Description>DCLA-000290</Description><Synonyms/><Note>Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C</Note><Position>193.0</Position></Entry><Entry><Code>CD3/CD_Evx</Code><ShortDescription>CD3/CD19 BiTE</ShortDescription><Description>DCLA-000048</Description><Synonyms/><Note>Catumaxomab Blinatumomab</Note><Position>194.0</Position></Entry><Entry><Code>CLDN18_QfG</Code><ShortDescription>CLDN18.2 BiTE</ShortDescription><Description>DCLA-000274</Description><Synonyms/><Note>Gresonitamab</Note><Position>195.0</Position></Entry><Entry><Code>DLL3 BiTE</Code><ShortDescription>DLL3 BiTE</ShortDescription><Description>DCLA-000241</Description><Synonyms/><Note>Tarlatamab Anti-DLL3/CD3 BiTE Antibody AMG 757</Note><Position>196.0</Position></Entry><Entry><Code>FLT3 BiTE</Code><ShortDescription>FLT3 BiTE</ShortDescription><Description>DCLA-000247</Description><Synonyms/><Note>Emirodatamab</Note><Position>197.0</Position></Entry><Entry><Code>MUC17/_N6N</Code><ShortDescription>MUC17/CD3 BiTE Antibody</ShortDescription><Description>DCLA-000245</Description><Synonyms/><Note>AMG 199</Note><Position>198.0</Position></Entry><Entry><Code>PSMA BiTE</Code><ShortDescription>PSMA BiTE</ShortDescription><Description>DCLA-000239</Description><Synonyms/><Note>Acapatamab</Note><Position>199.0</Position></Entry><Entry><Code>DLL3 CAR-T</Code><ShortDescription>DLL3 CAR-T</ShortDescription><Description>DCLA-000242</Description><Synonyms/><Note>AMG 119</Note><Position>200.0</Position></Entry><Entry><Code>PSMA-b_YkU</Code><ShortDescription>PSMA-binding radio conjugate</ShortDescription><Description>DCLA-000197</Description><Synonyms/><Note>Lutetium Lu-177 Capromab</Note><Position>201.0</Position></Entry><Entry><Code>SSTR2-_eKN</Code><ShortDescription>SSTR2-binding radio conjugate</ShortDescription><Description>DCLA-000196</Description><Synonyms/><Note>Lutetium Lu 177 Dotatate</Note><Position>202.0</Position></Entry><Entry><Code>SSTR3-_DCF</Code><ShortDescription>SSTR3-binding radio conjugate</ShortDescription><Description>DCLA-000198</Description><Synonyms/><Note/><Position>203.0</Position></Entry><Entry><Code>PD-1/I_1wC</Code><ShortDescription>PD-1/IL21-mutein BFFP</ShortDescription><Description>DCLA-000246</Description><Synonyms/><Note>Latikafusp</Note><Position>204.0</Position></Entry><Entry><Code>CDH17/_RZ7</Code><ShortDescription>CDH17/TRAIL bispecific antibody</ShortDescription><Description>DCLA-000087</Description><Synonyms/><Note>BI905711</Note><Position>205.0</Position></Entry><Entry><Code>TRAIL-_cA8</Code><ShortDescription>TRAIL-R1 antibody</ShortDescription><Description>DCLA-000085</Description><Synonyms/><Note>Mapatumumab</Note><Position>206.0</Position></Entry><Entry><Code>TRAIL-_Ays</Code><ShortDescription>TRAIL-R2 antibody</ShortDescription><Description>DCLA-000086</Description><Synonyms/><Note>Tigatuzumab</Note><Position>207.0</Position></Entry><Entry><Code>AXL ADC</Code><ShortDescription>AXL ADC</ShortDescription><Description>DCLA-000302</Description><Synonyms/><Note>Enapotamab Vedotin</Note><Position>208.0</Position></Entry><Entry><Code>BCMA ADC</Code><ShortDescription>BCMA ADC</ShortDescription><Description>DCLA-000285</Description><Synonyms/><Note>Anti-BCMA Antibody-drug Conjugate CC-99712 Belantamab Mafodotin MEDI2228 AMG 224 HDP-101</Note><Position>209.0</Position></Entry><Entry><Code>CD19 ADC</Code><ShortDescription>CD19 ADC</ShortDescription><Description>DCLA-000300</Description><Synonyms/><Note>Loncastuximab Tesirine SGN-CD19B</Note><Position>210.0</Position></Entry><Entry><Code>CD22 ADC</Code><ShortDescription>CD22 ADC</ShortDescription><Description>DCLA-000301</Description><Synonyms/><Note>Pinatuzumab Vedotin Epratuzumab-cys-tesirine TRPH-222</Note><Position>211.0</Position></Entry><Entry><Code>CD228 ADC</Code><ShortDescription>CD228 ADC</ShortDescription><Description>DCLA-000294</Description><Synonyms/><Note>SGN-CD228A</Note><Position>212.0</Position></Entry><Entry><Code>CD276 ADC</Code><ShortDescription>CD276 ADC</ShortDescription><Description>DCLA-000312</Description><Synonyms/><Note>Mirzotamab Clezutoclax Vobramitamab Duocarmazine Ifinatamab Deruxtecan</Note><Position>213.0</Position></Entry><Entry><Code>CD30 ADC</Code><ShortDescription>CD30 ADC</ShortDescription><Description>DCLA-000049</Description><Synonyms/><Note>Brentuximab Vedotin</Note><Position>214.0</Position></Entry><Entry><Code>CD33 ADC</Code><ShortDescription>CD33 ADC</ShortDescription><Description>DCLA-000050</Description><Synonyms/><Note>Actinium Ac 225 Lintuzumab Gemtuzumab Ozogamicin Vadastuximab Talirine Anti-CD33 Antibody-drug Conjugate IMGN779</Note><Position>215.0</Position></Entry><Entry><Code>CD37 ADC</Code><ShortDescription>CD37 ADC</ShortDescription><Description>DCLA-000304</Description><Synonyms/><Note>AGS67E</Note><Position>216.0</Position></Entry><Entry><Code>CD38 ADC</Code><ShortDescription>CD38 ADC</ShortDescription><Description>DCLA-000305</Description><Synonyms/><Note>STI-6129</Note><Position>217.0</Position></Entry><Entry><Code>CD46 ADC</Code><ShortDescription>CD46 ADC</ShortDescription><Description>DCLA-000306</Description><Synonyms/><Note>FOR46</Note><Position>218.0</Position></Entry><Entry><Code>CD47 ADC</Code><ShortDescription>CD47 ADC</ShortDescription><Description>DCLA-000308</Description><Synonyms/><Note>SGN-CD47M</Note><Position>219.0</Position></Entry><Entry><Code>CD48 ADC</Code><ShortDescription>CD48 ADC</ShortDescription><Description>DCLA-000309</Description><Synonyms/><Note>SGN-CD48A</Note><Position>220.0</Position></Entry><Entry><Code>CD7 ADC</Code><ShortDescription>CD7 ADC</ShortDescription><Description>DCLA-000303</Description><Synonyms/><Note>Anti-CD3/CD7-Ricin Toxin A Immunotoxin</Note><Position>221.0</Position></Entry><Entry><Code>CD70 ADC</Code><ShortDescription>CD70 ADC</ShortDescription><Description>DCLA-000310</Description><Synonyms/><Note>MDX-1203 Vorsetzumab Mafodotin</Note><Position>222.0</Position></Entry><Entry><Code>CD74 ADC</Code><ShortDescription>CD74 ADC</ShortDescription><Description>DCLA-000311</Description><Synonyms/><Note>STRO-001</Note><Position>223.0</Position></Entry><Entry><Code>CDH6 ADC</Code><ShortDescription>CDH6 ADC</ShortDescription><Description>DCLA-000313</Description><Synonyms/><Note>DS-6000a</Note><Position>224.0</Position></Entry><Entry><Code>CEACAM_b5k</Code><ShortDescription>CEACAM5 ADC</ShortDescription><Description>DCLA-000314</Description><Synonyms/><Note>Labetuzumab Govitecan Tusamitamab Ravtansine</Note><Position>225.0</Position></Entry><Entry><Code>CLDN18_Gzc</Code><ShortDescription>CLDN18.2 ADC</ShortDescription><Description>DCLA-000298</Description><Synonyms/><Note>LM-302 CMG901 CPO102</Note><Position>226.0</Position></Entry><Entry><Code>CLDN6 ADC</Code><ShortDescription>CLDN6 ADC</ShortDescription><Description>DCLA-000299</Description><Synonyms/><Note>SC-004 DS9606a</Note><Position>227.0</Position></Entry><Entry><Code>CLEC12_G0E</Code><ShortDescription>CLEC12A ADC</ShortDescription><Description>DCLA-000315</Description><Synonyms/><Note>DCLL9718S</Note><Position>228.0</Position></Entry><Entry><Code>DLL3 ADC</Code><ShortDescription>DLL3 ADC</ShortDescription><Description>DCLA-000233</Description><Synonyms/><Note>Rovalpituzumab Tesirine SC-002</Note><Position>229.0</Position></Entry><Entry><Code>DPEP3 ADC</Code><ShortDescription>DPEP3 ADC</ShortDescription><Description>DCLA-000319</Description><Synonyms/><Note>Tamrintamab Pamozirine</Note><Position>230.0</Position></Entry><Entry><Code>EDNRB ADC</Code><ShortDescription>EDNRB ADC</ShortDescription><Description>DCLA-000318</Description><Synonyms/><Note>DEDN6526A</Note><Position>231.0</Position></Entry><Entry><Code>EGFR ADC</Code><ShortDescription>EGFR ADC</ShortDescription><Description>DCLA-000291</Description><Synonyms/><Note>Laprituximab Emtansine Depatuxizumab Mafodotin Losatuxizumab Vedotin</Note><Position>232.0</Position></Entry><Entry><Code>ENPP3 ADC</Code><ShortDescription>ENPP3 ADC</ShortDescription><Description>DCLA-000316</Description><Synonyms/><Note>AGS-16C3F AGS-16M8F</Note><Position>233.0</Position></Entry><Entry><Code>F3 ADC</Code><ShortDescription>F3 ADC</ShortDescription><Description>DCLA-000317</Description><Synonyms/><Note>XB002</Note><Position>234.0</Position></Entry><Entry><Code>FCRL5 ADC</Code><ShortDescription>FCRL5 ADC</ShortDescription><Description>DCLA-000320</Description><Synonyms/><Note>DFRF4539A</Note><Position>235.0</Position></Entry><Entry><Code>FGFR2 ADC</Code><ShortDescription>FGFR2 ADC</ShortDescription><Description>DCLA-000321</Description><Synonyms/><Note>Aprutumab Ixadotin</Note><Position>236.0</Position></Entry><Entry><Code>FGFR3 ADC</Code><ShortDescription>FGFR3 ADC</ShortDescription><Description>DCLA-000322</Description><Synonyms/><Note>LY3076226</Note><Position>237.0</Position></Entry><Entry><Code>FLT3 ADC</Code><ShortDescription>FLT3 ADC</ShortDescription><Description>DCLA-000323</Description><Synonyms/><Note>AGS62P1</Note><Position>238.0</Position></Entry><Entry><Code>FOLR1 ADC</Code><ShortDescription>FOLR1 ADC</ShortDescription><Description>DCLA-000074</Description><Synonyms/><Note>Mirvetuximab Soravtansine STRO-002</Note><Position>239.0</Position></Entry><Entry><Code>GPNMB ADC</Code><ShortDescription>GPNMB ADC</ShortDescription><Description>DCLA-000324</Description><Synonyms/><Note>Glembatumumab Vedotin</Note><Position>240.0</Position></Entry><Entry><Code>GUCY2C ADC</Code><ShortDescription>GUCY2C ADC</ShortDescription><Description>DCLA-000325</Description><Synonyms/><Note>Indusatumab Vedotin TAK-164</Note><Position>241.0</Position></Entry><Entry><Code>HER2 ADC</Code><ShortDescription>HER2 ADC</ShortDescription><Description>DCLA-000076</Description><Synonyms/><Note>Trastuzumab Deruxtecan ADCT-502 Trastuzumab Emtansine Anti-HER2 Antibody-drug Conjugate MEDI4276 Anti-HER2 Antibody-drug Conjugate A166 Anti-HER2-DM1 Antibody-drug Conjugate GQ1001 Anti-HER2/MMAE Antibody-drug Conjugate MRG002 Anti-HER2 Antibody-drug Conjugate ARX788 XMT-1522 PF-06804103 DHES0815A ZW49</Note><Position>242.0</Position></Entry><Entry><Code>HAVCR1 ADC</Code><ShortDescription>HAVCR1 ADC</ShortDescription><Description>DCLA-000326</Description><Synonyms/><Note>CDX-014</Note><Position>243.0</Position></Entry><Entry><Code>MET ADC</Code><ShortDescription>MET ADC</ShortDescription><Description>DCLA-000283</Description><Synonyms/><Note>Anti-c-Met Antibody-drug Conjugate HTI-1066 Anti-c-Met Antibody-drug Conjugate TR1801</Note><Position>244.0</Position></Entry><Entry><Code>IL2RA ADC</Code><ShortDescription>IL2RA ADC</ShortDescription><Description>DCLA-000327</Description><Synonyms/><Note>Camidanlumab Tesirine</Note><Position>245.0</Position></Entry><Entry><Code>IL3RA ADC</Code><ShortDescription>IL3RA ADC</ShortDescription><Description>DCLA-000329</Description><Synonyms/><Note>SGN-CD123A IMGN632</Note><Position>246.0</Position></Entry><Entry><Code>ITGB6 ADC</Code><ShortDescription>ITGB6 ADC</ShortDescription><Description>DCLA-000330</Description><Synonyms/><Note>SGN-B6A</Note><Position>247.0</Position></Entry><Entry><Code>LRRC15 ADC</Code><ShortDescription>LRRC15 ADC</ShortDescription><Description>DCLA-000331</Description><Synonyms/><Note>Samrotamab Vedotin</Note><Position>248.0</Position></Entry><Entry><Code>LY6E ADC</Code><ShortDescription>LY6E ADC</ShortDescription><Description>DCLA-000332</Description><Synonyms/><Note>RG 7841</Note><Position>249.0</Position></Entry><Entry><Code>LY75 ADC</Code><ShortDescription>LY75 ADC</ShortDescription><Description>DCLA-000333</Description><Synonyms/><Note>OBT076</Note><Position>250.0</Position></Entry><Entry><Code>MSLN ADC</Code><ShortDescription>MSLN ADC</ShortDescription><Description>DCLA-000073</Description><Synonyms/><Note>Anetumab Ravtansine Anti-mesothelin Antibody-drug Conjugate BMS-986148 Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A</Note><Position>251.0</Position></Entry><Entry><Code>MUC16 ADC</Code><ShortDescription>MUC16 ADC</ShortDescription><Description>DCLA-000284</Description><Synonyms/><Note>DMUC4064A</Note><Position>252.0</Position></Entry><Entry><Code>NECTIN_NFu</Code><ShortDescription>NECTIN4 ADC</ShortDescription><Description>DCLA-000075</Description><Synonyms/><Note>Enfortumab Vedotin</Note><Position>253.0</Position></Entry><Entry><Code>PTK7 ADC</Code><ShortDescription>PTK7 ADC</ShortDescription><Description>DCLA-000334</Description><Synonyms/><Note>Cofetuzumab Pelidotin</Note><Position>254.0</Position></Entry><Entry><Code>RNF43 ADC</Code><ShortDescription>RNF43 ADC</ShortDescription><Description>DCLA-000335</Description><Synonyms/><Note>SC-006</Note><Position>255.0</Position></Entry><Entry><Code>ROR1 ADC</Code><ShortDescription>ROR1 ADC</ShortDescription><Description>DCLA-000295</Description><Synonyms/><Note>Zilovertamab Vedotin Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002</Note><Position>256.0</Position></Entry><Entry><Code>ROR2 ADC</Code><ShortDescription>ROR2 ADC</ShortDescription><Description>DCLA-000296</Description><Synonyms/><Note>Ozuriftamab Vedotin</Note><Position>257.0</Position></Entry><Entry><Code>TF ADC</Code><ShortDescription>TF ADC</ShortDescription><Description>DCLA-000077</Description><Synonyms/><Note>Tisotumab Vedotin</Note><Position>258.0</Position></Entry><Entry><Code>TFRC ADC</Code><ShortDescription>TFRC ADC</ShortDescription><Description>DCLA-000339</Description><Synonyms/><Note>CX-2029</Note><Position>259.0</Position></Entry><Entry><Code>Trop2 ADC</Code><ShortDescription>Trop2 ADC</ShortDescription><Description>DCLA-000034</Description><Synonyms/><Note>Sacituzumab Govitecan PF-06664178 SKB264 Datopotamab Deruxtecan</Note><Position>260.0</Position></Entry><Entry><Code>SLAMF6 ADC</Code><ShortDescription>SLAMF6 ADC</ShortDescription><Description>DCLA-000297</Description><Synonyms/><Note>Anti-CD352 Antibody-drug Conjugate SGN-CD352A</Note><Position>261.0</Position></Entry><Entry><Code>SLAMF7 ADC</Code><ShortDescription>SLAMF7 ADC</ShortDescription><Description>DCLA-000292</Description><Synonyms/><Note>Azintuxizumab Vedotin</Note><Position>262.0</Position></Entry><Entry><Code>SLC34A_LAV</Code><ShortDescription>SLC34A2 ADC</ShortDescription><Description>DCLA-000336</Description><Synonyms/><Note>Lifastuzumab Vedotin Upifitamab Rilsodotin</Note><Position>263.0</Position></Entry><Entry><Code>SLITRK_FPQ</Code><ShortDescription>SLITRK6 ADC</ShortDescription><Description>DCLA-000342</Description><Synonyms/><Note>Sirtratumab Vedotin</Note><Position>264.0</Position></Entry><Entry><Code>SSTR2 MDC</Code><ShortDescription>SSTR2 MDC</ShortDescription><Description>DCLA-000337</Description><Synonyms/><Note>Nendratareotide Uzatansine</Note><Position>265.0</Position></Entry><Entry><Code>STEAP1 ADC</Code><ShortDescription>STEAP1 ADC</ShortDescription><Description>DCLA-000338</Description><Synonyms/><Note>Vandortuzumab Vedotin</Note><Position>266.0</Position></Entry><Entry><Code>PSMA ADC</Code><ShortDescription>PSMA ADC</ShortDescription><Description>DCLA-000293</Description><Synonyms/><Note>MEDI3726 Anti-PSMA Monoclonal Antibody-MMAE Conjugate</Note><Position>267.0</Position></Entry><Entry><Code>VTCN1 ADC</Code><ShortDescription>VTCN1 ADC</ShortDescription><Description>DCLA-000340</Description><Synonyms/><Note>AZD8205</Note><Position>268.0</Position></Entry><Entry><Code>GUCY2C_+vY</Code><ShortDescription>GUCY2C radio conjugate</ShortDescription><Description>DCLA-000341</Description><Synonyms/><Note>Zirconium Zr 89-TAK-164</Note><Position>269.0</Position></Entry><Entry><Code>Alkyla_sSt</Code><ShortDescription>Alkylating agent</ShortDescription><Description>DCLA-000036</Description><Synonyms/><Note>Lobaplatin Nedaplatin Streptozocin Altretamine Bendamustine Busulfan Carboplatin Carmustine Chlorambucil Cisplatin Cyclophosphamide Dacarbazine Mechlorethamine Melphalan Procarbazine Temozolomide Thiotepa Trabectedin Treosulfan</Note><Position>270.0</Position></Entry><Entry><Code>Anthra_J0M</Code><ShortDescription>Anthracenedione</ShortDescription><Description>DCLA-000038</Description><Synonyms/><Note>Mitoxantrone</Note><Position>271.0</Position></Entry><Entry><Code>Anthra_8js</Code><ShortDescription>Anthracycline</ShortDescription><Description>DCLA-000039</Description><Synonyms/><Note>Aclarubicin Amrubicin Epirubicin Pirarubicin Valrubicin Daunorubicin Doxorubicin Idarubicin Aldoxorubicin Camsirubicin</Note><Position>272.0</Position></Entry><Entry><Code>Antime_Ci5</Code><ShortDescription>Antimetabolite</ShortDescription><Description>DCLA-000098</Description><Synonyms/><Note>Nolatrexed Pentostatin Trimethoprim-Sulfamethoxazole Aminopterin Cladribine Clofarabine Cytarabine Dacarbazine Fludarabine Gemcitabine Mercaptopurine Methotrexate Nelarabine Pemetrexed Pralatrexate Raltitrexed Thioguanine</Note><Position>273.0</Position></Entry><Entry><Code>Deoxyc_iUE</Code><ShortDescription>Deoxycytidine analogue</ShortDescription><Description>DCLA-000124</Description><Synonyms/><Note>Cytarabine</Note><Position>274.0</Position></Entry><Entry><Code>Fluoro_BxK</Code><ShortDescription>Fluoropyrimidine</ShortDescription><Description>DCLA-000139</Description><Synonyms/><Note>Doxifluridine Fluorouracil Capecitabine Floxuridine</Note><Position>275.0</Position></Entry><Entry><Code>Human _yfX</Code><ShortDescription>Human DNA synthesis inhibitor</ShortDescription><Description>DCLA-000154</Description><Synonyms/><Note>Amsacrine Bleomycin Dactinomycin Epirubicin Mitomycin Plicamycin Dacarbazine Fludarabine Hydroxyurea Procarbazine</Note><Position>276.0</Position></Entry><Entry><Code>Immuno_GFH</Code><ShortDescription>Immunomodulatory drugs (IMiDs)</ShortDescription><Description>DCLA-000158</Description><Synonyms/><Note>Lenalidomide Pomalidomide Thalidomide</Note><Position>277.0</Position></Entry><Entry><Code>Platin_Zg8</Code><ShortDescription>Platinum agent</ShortDescription><Description>DCLA-000187</Description><Synonyms/><Note>Lobaplatin Nedaplatin Carboplatin Cisplatin Oxaliplatin</Note><Position>278.0</Position></Entry><Entry><Code>Purine_BPi</Code><ShortDescription>Purine analogue</ShortDescription><Description>DCLA-000193</Description><Synonyms/><Note>Pentostatin Cladribine Clofarabine Dacarbazine Fludarabine Mercaptopurine Nelarabine Thioguanine</Note><Position>279.0</Position></Entry><Entry><Code>Pyrimi_4Q4</Code><ShortDescription>Pyrimidine analogue</ShortDescription><Description>DCLA-000195</Description><Synonyms/><Note>Sapacitabine Azacitidine Decitabine Gemcitabine</Note><Position>280.0</Position></Entry><Entry><Code>Taxane</Code><ShortDescription>Taxane</ShortDescription><Description>DCLA-000211</Description><Synonyms/><Note>Tesetaxel Cabazitaxel Docetaxel Paclitaxel Taxane Analogue TPI 287 Nab-paclitaxel</Note><Position>281.0</Position></Entry><Entry><Code>Topois_pQ4</Code><ShortDescription>Topoisomerase inhibitor</ShortDescription><Description>DCLA-000215</Description><Synonyms/><Note>Belotecan Irinotecan Topotecan Aclarubicin Amrubicin Amsacrine Epirubicin Vosaroxin Daunorubicin Doxorubicin Etoposide Idarubicin Mitoxantrone Pixantrone Teniposide</Note><Position>282.0</Position></Entry><Entry><Code>Triazene</Code><ShortDescription>Triazene</ShortDescription><Description>DCLA-000216</Description><Synonyms/><Note>Dacarbazine Procarbazine Temozolomide</Note><Position>283.0</Position></Entry><Entry><Code>Vinca _lhR</Code><ShortDescription>Vinca alkaloid</ShortDescription><Description>DCLA-000228</Description><Synonyms/><Note>Vindesine Vinflunine Vinblastine Vincristine Vinorelbine</Note><Position>284.0</Position></Entry><Entry><Code>5 alph_xa8</Code><ShortDescription>5 alpha-reductase  inhibitor</ShortDescription><Description>DCLA-000035</Description><Synonyms/><Note>Dutasteride Finasteride</Note><Position>285.0</Position></Entry><Entry><Code>Antian_O3e</Code><ShortDescription>Antiandrogen</ShortDescription><Description>DCLA-000091</Description><Synonyms/><Note>Abiraterone Dutasteride Finasteride Galeterone Leuprolide Orteronel Triptorelin Ketoconazole Rezvilutamide</Note><Position>286.0</Position></Entry><Entry><Code>Aromat_S/m</Code><ShortDescription>Aromatase inhibitor</ShortDescription><Description>DCLA-000104</Description><Synonyms/><Note>Aminoglutethimide Anastrozole Exemestane Letrozole</Note><Position>287.0</Position></Entry><Entry><Code>Endocr_Klf</Code><ShortDescription>Endocrine therapeutic</ShortDescription><Description>DCLA-000131</Description><Synonyms/><Note>Danazol Diethylstilbestrol Medroxyprogesterone Megestrol</Note><Position>288.0</Position></Entry><Entry><Code>Estrog_PZx</Code><ShortDescription>Estrogen receptor inhibitor</ShortDescription><Description>DCLA-000135</Description><Synonyms/><Note>Fulvestrant</Note><Position>289.0</Position></Entry><Entry><Code>GnRH a_Qii</Code><ShortDescription>GnRH agonist</ShortDescription><Description>DCLA-000141</Description><Synonyms/><Note>Goserelin Histrelin Leuprolide Triptorelin</Note><Position>290.0</Position></Entry><Entry><Code>GnRH a_oGK</Code><ShortDescription>GnRH antagonist</ShortDescription><Description>DCLA-000142</Description><Synonyms/><Note>Degarelix</Note><Position>291.0</Position></Entry><Entry><Code>Nonste_gLU</Code><ShortDescription>Nonsteroidal antiandrogen</ShortDescription><Description>DCLA-000171</Description><Synonyms/><Note>Cimetidine Flutamide Apalutamide Bicalutamide Darolutamide Enzalutamide Nilutamide</Note><Position>292.0</Position></Entry><Entry><Code>Select_unq</Code><ShortDescription>Selective estrogen receptor modulator</ShortDescription><Description>DCLA-000202</Description><Synonyms/><Note>Raloxifene Tamoxifen Toremifene</Note><Position>293.0</Position></Entry><Entry><Code>Somato_VHG</Code><ShortDescription>Somatostatin analog</ShortDescription><Description>DCLA-000205</Description><Synonyms/><Note>Lanreotide Octreotide</Note><Position>294.0</Position></Entry><Entry><Code>Steroi_iBc</Code><ShortDescription>Steroid synthesis inhibitor</ShortDescription><Description>DCLA-000208</Description><Synonyms/><Note>Abiraterone Galeterone Orteronel Aminoglutethimide Anastrozole Exemestane Letrozole</Note><Position>295.0</Position></Entry><Entry><Code>Steroi_DAe</Code><ShortDescription>Steroidal androgen receptor inhibitor</ShortDescription><Description>DCLA-000209</Description><Synonyms/><Note>Galeterone</Note><Position>296.0</Position></Entry><Entry><Code>C5 ab</Code><ShortDescription>C5 antibody</ShortDescription><Description>DCLA-000041</Description><Synonyms/><Note>Eculizumab Ravulizumab</Note><Position>297.0</Position></Entry><Entry><Code>Factor_hUl</Code><ShortDescription>Factor IXa antibody</ShortDescription><Description>DCLA-000060</Description><Synonyms/><Note>Emicizumab</Note><Position>298.0</Position></Entry><Entry><Code>Factor_xas</Code><ShortDescription>Factor Xa antibody</ShortDescription><Description>DCLA-000061</Description><Synonyms/><Note>Emicizumab</Note><Position>299.0</Position></Entry><Entry><Code>vWF me_mhC</Code><ShortDescription>vWF medication</ShortDescription><Description>DCLA-000090</Description><Synonyms/><Note>Caplacizumab</Note><Position>300.0</Position></Entry><Entry><Code>CXCR4 i</Code><ShortDescription>CXCR4 inhibitor</ShortDescription><Description>DCLA-000121</Description><Synonyms/><Note>Plerixafor</Note><Position>301.0</Position></Entry><Entry><Code>Granul_YGi</Code><ShortDescription>Granulocyte colony-stimulating factor</ShortDescription><Description>DCLA-000144</Description><Synonyms/><Note>Filgrastim Filgrastim-sndz Lenograstim Pegfilgrastim Tbo-filgrastim</Note><Position>302.0</Position></Entry><Entry><Code>Granul_CfP</Code><ShortDescription>Granulocyte macrophage colony-stimulating  factor</ShortDescription><Description>DCLA-000145</Description><Synonyms/><Note>Sargramostim</Note><Position>303.0</Position></Entry><Entry><Code>Hemato_Yfm</Code><ShortDescription>Hematopoietic growth factor</ShortDescription><Description>DCLA-000149</Description><Synonyms/><Note>Avatrombopag Eltrombopag Oprelvekin Romiplostim</Note><Position>304.0</Position></Entry><Entry><Code>Megaka_c7Y</Code><ShortDescription>Megakaryocyte growth factor</ShortDescription><Description>DCLA-000168</Description><Synonyms/><Note>Avatrombopag Eltrombopag Oprelvekin Romiplostim</Note><Position>305.0</Position></Entry><Entry><Code>Phosph_gXo</Code><ShortDescription>Phosphodiesterase inhibitor</ShortDescription><Description>DCLA-000182</Description><Synonyms/><Note>Anagrelide</Note><Position>306.0</Position></Entry><Entry><Code>diarrheal</Code><ShortDescription>diarrheal</ShortDescription><Description>DCLA-000056</Description><Synonyms/><Note>Loperamide</Note><Position>307.0</Position></Entry><Entry><Code>RANKL ab</Code><ShortDescription>RANKL antibody</ShortDescription><Description>DCLA-000083</Description><Synonyms/><Note>Denosumab</Note><Position>308.0</Position></Entry><Entry><Code>Antifolate</Code><ShortDescription>Antifolate</ShortDescription><Description>DCLA-000094</Description><Synonyms/><Note>Nolatrexed Trimethoprim-Sulfamethoxazole Aminopterin Methotrexate Pemetrexed Pralatrexate Raltitrexed</Note><Position>309.0</Position></Entry><Entry><Code>Appeti_KCH</Code><ShortDescription>Appetite stimulant</ShortDescription><Description>DCLA-000103</Description><Synonyms/><Note>Megestrol</Note><Position>310.0</Position></Entry><Entry><Code>Bispho_o7J</Code><ShortDescription>Bisphosphonate</ShortDescription><Description>DCLA-000111</Description><Synonyms/><Note>Alendronic Acid Clodronic Acid Ibandronic Acid Pamidronic Acid Zoledronic Acid</Note><Position>311.0</Position></Entry><Entry><Code>Cannab_5ag</Code><ShortDescription>Cannabinoid</ShortDescription><Description>DCLA-000114</Description><Synonyms/><Note>Dronabinol Nabilone</Note><Position>312.0</Position></Entry><Entry><Code>Dopami_FyA</Code><ShortDescription>Dopamine receptor antagonist</ShortDescription><Description>DCLA-000129</Description><Synonyms/><Note>Domperidone Metoclopramide Olanzapine Prochlorperazine Promethazine</Note><Position>313.0</Position></Entry><Entry><Code>Emesis_xBZ</Code><ShortDescription>Emesis prevention</ShortDescription><Description>DCLA-000130</Description><Synonyms/><Note>Alprazolam Aprepitant Dolasetron Domperidone Dronabinol Fosaprepitant Granisetron Haloperidol Lorazepam Metoclopramide Nabilone Olanzapine Ondansetron Palonosetron Prochlorperazine Promethazine Ramosetron Rolapitant Scopolamine Tropisetron Thalidomide</Note><Position>314.0</Position></Entry><Entry><Code>NK1 an_QX8</Code><ShortDescription>NK1 antagonist</ShortDescription><Description>DCLA-000170</Description><Synonyms/><Note>Aprepitant Fosaprepitant Rolapitant</Note><Position>315.0</Position></Entry><Entry><Code>Phenot_Vgt</Code><ShortDescription>Phenothiazine</ShortDescription><Description>DCLA-000181</Description><Synonyms/><Note>Domperidone Prochlorperazine Promethazine</Note><Position>316.0</Position></Entry><Entry><Code>Seroto_9Ql</Code><ShortDescription>Serotonin 5-HT3 antagonist</ShortDescription><Description>DCLA-000203</Description><Synonyms/><Note>Dolasetron Granisetron Ondansetron Palonosetron Ramosetron Tropisetron</Note><Position>317.0</Position></Entry><Entry><Code>Steroid</Code><ShortDescription>Steroid</ShortDescription><Description>DCLA-000207</Description><Synonyms/><Note>Dexamethasone Methylprednisolone Prednisolone Prednisone</Note><Position>318.0</Position></Entry><Entry><Code>Trypto_Ddl</Code><ShortDescription>Tryptophan hydroxylase inhibitor</ShortDescription><Description>DCLA-000217</Description><Synonyms/><Note>Telotristat</Note><Position>319.0</Position></Entry><Entry><Code>Uric a_mxm</Code><ShortDescription>Uric acid lowering agent</ShortDescription><Description>DCLA-000226</Description><Synonyms/><Note>Rasburicase</Note><Position>320.0</Position></Entry><Entry><Code>COX-1 i</Code><ShortDescription>COX-1 inhibitor</ShortDescription><Description>DCLA-000118</Description><Synonyms/><Note>Aspirin Indomethacin</Note><Position>321.0</Position></Entry><Entry><Code>COX-2 i</Code><ShortDescription>COX-2 inhibitor</ShortDescription><Description>DCLA-000119</Description><Synonyms/><Note>Indomethacin</Note><Position>322.0</Position></Entry><Entry><Code>GPIIb-_FHC</Code><ShortDescription>GPIIb-IIIa antibody</ShortDescription><Description>DCLA-000063</Description><Synonyms/><Note>Abciximab</Note><Position>323.0</Position></Entry><Entry><Code>Antico_fhO</Code><ShortDescription>Anticoagulant</ShortDescription><Description>DCLA-000093</Description><Synonyms/><Note>Argatroban Bivalirudin Dalteparin Enoxaparin Fondaparinux Lepirudin Semuloparin Tinzaparin Warfarin</Note><Position>324.0</Position></Entry><Entry><Code>Coagul_HRt</Code><ShortDescription>Coagulation factor</ShortDescription><Description>DCLA-000117</Description><Synonyms/><Note/><Position>325.0</Position></Entry><Entry><Code>Direct_FhF</Code><ShortDescription>Direct oral anticoagulant</ShortDescription><Description>DCLA-000125</Description><Synonyms/><Note>Apixaban Betrixaban Dabigatran Edoxaban Rivaroxaban</Note><Position>326.0</Position></Entry><Entry><Code>Direct_SLk</Code><ShortDescription>Direct thrombin inhibitor</ShortDescription><Description>DCLA-000126</Description><Synonyms/><Note>Argatroban Bivalirudin Dabigatran Lepirudin</Note><Position>327.0</Position></Entry><Entry><Code>Factor_KVW</Code><ShortDescription>Factor Xa inhibitor</ShortDescription><Description>DCLA-000136</Description><Synonyms/><Note>Apixaban Betrixaban Edoxaban Rivaroxaban</Note><Position>328.0</Position></Entry><Entry><Code>GPIIb-_z3Q</Code><ShortDescription>GPIIb-IIIa inhibitor</ShortDescription><Description>DCLA-000143</Description><Synonyms/><Note>Eptifibatide Tirofiban</Note><Position>329.0</Position></Entry><Entry><Code>Hemost_9zc</Code><ShortDescription>Hemostasis medication</ShortDescription><Description>DCLA-000150</Description><Synonyms/><Note>Desmopressin Idarucizumab</Note><Position>330.0</Position></Entry><Entry><Code>P2Y12 _mGY</Code><ShortDescription>P2Y12 ADP inhibitor</ShortDescription><Description>DCLA-000173</Description><Synonyms/><Note>Cangrelor Clopidogrel Prasugrel Ticagrelor Ticlopidine</Note><Position>331.0</Position></Entry><Entry><Code>Ultral_NNQ</Code><ShortDescription>Ultralow molecular weight heparin</ShortDescription><Description>DCLA-000225</Description><Synonyms/><Note>Semuloparin</Note><Position>332.0</Position></Entry><Entry><Code>Vitami_MnA</Code><ShortDescription>Vitamin K antagonist</ShortDescription><Description>DCLA-000230</Description><Synonyms/><Note>Warfarin</Note><Position>333.0</Position></Entry><Entry><Code>Antiba_jr0</Code><ShortDescription>Antibacterial</ShortDescription><Description>DCLA-000092</Description><Synonyms/><Note>Clarithromycin Dapsone Trimethoprim-Sulfamethoxazole Aztreonam</Note><Position>334.0</Position></Entry><Entry><Code>Antifungal</Code><ShortDescription>Antifungal</ShortDescription><Description>DCLA-000095</Description><Synonyms/><Note>Caspofungin Fluconazole Itraconazole Pentamidine Voriconazole Ketoconazole</Note><Position>335.0</Position></Entry><Entry><Code>Antiviral</Code><ShortDescription>Antiviral</ShortDescription><Description>DCLA-000102</Description><Synonyms/><Note>Famciclovir Lamivudine Acyclovir Entecavir Atazanavir Efavirenz Oseltamivir</Note><Position>336.0</Position></Entry><Entry><Code>Fluoro_6AE</Code><ShortDescription>Fluoroquinolone</ShortDescription><Description>DCLA-000140</Description><Synonyms/><Note>Ciprofloxacin Levofloxacin</Note><Position>337.0</Position></Entry><Entry><Code>PCP pr_KxU</Code><ShortDescription>PCP prophylaxis</ShortDescription><Description>DCLA-000177</Description><Synonyms/><Note>Atovaquone Dapsone Pentamidine Trimethoprim-Sulfamethoxazole</Note><Position>338.0</Position></Entry><Entry><Code>Penicillin</Code><ShortDescription>Penicillin</ShortDescription><Description>DCLA-000180</Description><Synonyms/><Note>Amoxicillin Penicillin V</Note><Position>339.0</Position></Entry><Entry><Code>Viral _zGK</Code><ShortDescription>Viral DNA synthesis inhibitor</ShortDescription><Description>DCLA-000229</Description><Synonyms/><Note>Valacyclovir Valganciclovir Zidovudine</Note><Position>340.0</Position></Entry><Entry><Code>Antihi_pja</Code><ShortDescription>Antihistamine</ShortDescription><Description>DCLA-000096</Description><Synonyms/><Note>Cetirizine Clemastine Dexchlorpheniramine Diphenhydramine Hydroxyzine</Note><Position>341.0</Position></Entry><Entry><Code>Antile_K6C</Code><ShortDescription>Antileukotriene</ShortDescription><Description>DCLA-000097</Description><Synonyms/><Note>Montelukast</Note><Position>342.0</Position></Entry><Entry><Code>Antips_9Ug</Code><ShortDescription>Antipsychotic</ShortDescription><Description>DCLA-000099</Description><Synonyms/><Note>Haloperidol Olanzapine</Note><Position>343.0</Position></Entry><Entry><Code>Antipy_2vI</Code><ShortDescription>Antipyretic</ShortDescription><Description>DCLA-000100</Description><Synonyms/><Note>Acetaminophen Aspirin Indomethacin</Note><Position>344.0</Position></Entry><Entry><Code>Benzod_BWO</Code><ShortDescription>Benzodiazepine</ShortDescription><Description>DCLA-000110</Description><Synonyms/><Note>Alprazolam Clonazepam Lorazepam</Note><Position>345.0</Position></Entry><Entry><Code>Chemot_S7O</Code><ShortDescription>Chemotherapy protective agent</ShortDescription><Description>DCLA-000116</Description><Synonyms/><Note>Amifostine Defibrotide Glucarpidase Levoleucovorin Mannitol Mesna Palifermin</Note><Position>346.0</Position></Entry><Entry><Code>Diuretic</Code><ShortDescription>Diuretic</ShortDescription><Description>DCLA-000127</Description><Synonyms/><Note>Furosemide</Note><Position>347.0</Position></Entry><Entry><Code>PDE i</Code><ShortDescription>PDE inhibitor</ShortDescription><Description>DCLA-000178</Description><Synonyms/><Note>Cilostazol Dipyridamole</Note><Position>348.0</Position></Entry><Entry><Code>Xanthi_bAH</Code><ShortDescription>Xanthine oxidase inhibitor</ShortDescription><Description>DCLA-000231</Description><Synonyms/><Note>Allopurinol</Note><Position>349.0</Position></Entry><Entry><Code>IMPDH2 i</Code><ShortDescription>IMPDH2 inhibitor</ShortDescription><Description>DCLA-000368</Description><Synonyms/><Note>Mycophenolate Mofetil</Note><Position>350.0</Position></Entry><Entry><Code>EGFR/M_YeU</Code><ShortDescription>EGFR/MET antibody</ShortDescription><Description>DCLA-000269</Description><Synonyms/><Note>Amivantamab</Note><Position>351.0</Position></Entry><Entry><Code>ERBB3 ADC</Code><ShortDescription>ERBB3 ADC</ShortDescription><Description>DCLA-000270</Description><Synonyms/><Note>Patritumab Deruxtecan</Note><Position>352.0</Position></Entry><Entry><Code>ERK i</Code><ShortDescription>ERK inhibitor</ShortDescription><Description>DCLA-000272</Description><Synonyms/><Note>Rineterkib ERK1/2 Inhibitor KO-947 ERK1/2 Inhibitor ERAS-007 ERK 1/2 Inhibitor ASTX029 Ulixertinib Temuterkib Ravoxertinib ERK1/2 Inhibitor HH2710 ERK1/2 Inhibitor JSI-1187</Note><Position>353.0</Position></Entry><Entry><Code>CLDN18_v7V</Code><ShortDescription>CLDN18.2 antibody mRNA</ShortDescription><Description>DCLA-000352</Description><Synonyms/><Note>BNT141</Note><Position>354.0</Position></Entry><Entry><Code>CLDN18_VYP</Code><ShortDescription>CLDN18.2/PD-L1 antibody</ShortDescription><Description>DCLA-000353</Description><Synonyms/><Note>Q-1802</Note><Position>355.0</Position></Entry><Entry><Code>CLDN18_bKn</Code><ShortDescription>CLDN18.2-binding radio conjugate</ShortDescription><Description>DCLA-000354</Description><Synonyms/><Note>Iodine I 124 18B10(10L)</Note><Position>356.0</Position></Entry><Entry><Code>CLDN18_Sda</Code><ShortDescription>CLDN18.2 CAR-T</ShortDescription><Description>DCLA-000355</Description><Synonyms/><Note>IBI345 LY011</Note><Position>357.0</Position></Entry><Entry><Code>CLDN18_6NT</Code><ShortDescription>CLDN18.2/CD3 antibody</ShortDescription><Description>DCLA-000356</Description><Synonyms/><Note>IBI389</Note><Position>358.0</Position></Entry><Entry><Code>CLDN18_Hid</Code><ShortDescription>CLDN18.2/CD137 antibody</ShortDescription><Description>DCLA-000357</Description><Synonyms/><Note>TJ-CD4B</Note><Position>359.0</Position></Entry><Entry><Code>gamma _sbT</Code><ShortDescription>gamma secretase inhibitor</ShortDescription><Description>DCLA-000358</Description><Synonyms/><Note>Nirogacestat</Note><Position>360.0</Position></Entry><Entry><Code>Chemot_6GS</Code><ShortDescription>Chemotherapy</ShortDescription><Description>DCLA-000360</Description><Synonyms/><Note>Arsenic Trioxide</Note><Position>361.0</Position></Entry><Entry><Code>FAK i</Code><ShortDescription>FAK inhibitor</ShortDescription><Description>DCLA-000362</Description><Synonyms/><Note>Defactinib</Note><Position>362.0</Position></Entry><Entry><Code>RAF1/M_yf6</Code><ShortDescription>RAF1/MEK1 inhibitor</ShortDescription><Description>DCLA-000363</Description><Synonyms/><Note>Avutometinib</Note><Position>363.0</Position></Entry><Entry><Code>FAP ADC</Code><ShortDescription>FAP ADC</ShortDescription><Description>DCLA-000364</Description><Synonyms/><Note>OMTX705</Note><Position>364.0</Position></Entry><Entry><Code>GNAQ/G_axK</Code><ShortDescription>GNAQ/GNA11 inhibitor</ShortDescription><Description>DCLA-000366</Description><Synonyms/><Note>DYP688 DYP688</Note><Position>365.0</Position></Entry><Entry><Code>PKC i</Code><ShortDescription>PKC inhibitor</ShortDescription><Description>DCLA-000367</Description><Synonyms/><Note>Darovasertib</Note><Position>366.0</Position></Entry><Entry><Code>TYK2 i</Code><ShortDescription>TYK2 inhibitor</ShortDescription><Description>DCLA-000369</Description><Synonyms/><Note>Deucravacitinib</Note><Position>367.0</Position></Entry></Entries><Categories><Category><Name>antineoplastic</Name><Position>1.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>Aminop_5bZ</Code></CategoryEntry><CategoryEntry><Code>CD19 ab</Code></CategoryEntry><CategoryEntry><Code>CD22 ab</Code></CategoryEntry><CategoryEntry><Code>CD27 ab</Code></CategoryEntry><CategoryEntry><Code>CD37 ab</Code></CategoryEntry><CategoryEntry><Code>CD46 ab</Code></CategoryEntry><CategoryEntry><Code>CD79B ab</Code></CategoryEntry><CategoryEntry><Code>CD194 ab</Code></CategoryEntry><CategoryEntry><Code>DKK1 ab</Code></CategoryEntry><CategoryEntry><Code>EpCAM ab</Code></CategoryEntry><CategoryEntry><Code>GD2 ab</Code></CategoryEntry><CategoryEntry><Code>KIR ab</Code></CategoryEntry><CategoryEntry><Code>P-sele_gYI</Code></CategoryEntry><CategoryEntry><Code>PS ab</Code></CategoryEntry><CategoryEntry><Code>VEGFR ab</Code></CategoryEntry><CategoryEntry><Code>Calcin_HIG</Code></CategoryEntry><CategoryEntry><Code>Microt_kDr</Code></CategoryEntry><CategoryEntry><Code>PAR1 i</Code></CategoryEntry><CategoryEntry><Code>Purine_o6e</Code></CategoryEntry><CategoryEntry><Code>Retinoid</Code></CategoryEntry><CategoryEntry><Code>Telome_vIx</Code></CategoryEntry><CategoryEntry><Code>XPO1 i</Code></CategoryEntry><CategoryEntry><Code>PKC i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>pi3k-akt-mtor</Name><Position>2.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>AKT i</Code></CategoryEntry><CategoryEntry><Code>MTOR i</Code></CategoryEntry><CategoryEntry><Code>MTORC1 i</Code></CategoryEntry><CategoryEntry><Code>MTORC1_aMs</Code></CategoryEntry><CategoryEntry><Code>MTORC2 i</Code></CategoryEntry><CategoryEntry><Code>PI3K a_uQZ</Code></CategoryEntry><CategoryEntry><Code>PI3K d_KRj</Code></CategoryEntry><CategoryEntry><Code>PI3K g_jqb</Code></CategoryEntry><CategoryEntry><Code>PI3K i</Code></CategoryEntry><CategoryEntry><Code>PI3K/A_+zE</Code></CategoryEntry><CategoryEntry><Code>TSC1 i</Code></CategoryEntry><CategoryEntry><Code>TSC2 i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>tk</Name><Position>3.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>ALK i</Code></CategoryEntry><CategoryEntry><Code>EGFR ab</Code></CategoryEntry><CategoryEntry><Code>EGFR/E_rLR</Code></CategoryEntry><CategoryEntry><Code>EGFR/E_IR2</Code></CategoryEntry><CategoryEntry><Code>ERBB2/_LV9</Code></CategoryEntry><CategoryEntry><Code>ERBB3 ab</Code></CategoryEntry><CategoryEntry><Code>FGFR2b ab</Code></CategoryEntry><CategoryEntry><Code>FGFR3 ab</Code></CategoryEntry><CategoryEntry><Code>HER2 ab</Code></CategoryEntry><CategoryEntry><Code>HGF ab</Code></CategoryEntry><CategoryEntry><Code>IGF-1R ab</Code></CategoryEntry><CategoryEntry><Code>Met ab</Code></CategoryEntry><CategoryEntry><Code>PDGFRA ab</Code></CategoryEntry><CategoryEntry><Code>VEGF ab</Code></CategoryEntry><CategoryEntry><Code>AXL i</Code></CategoryEntry><CategoryEntry><Code>BCR-ABL i</Code></CategoryEntry><CategoryEntry><Code>BTK i</Code></CategoryEntry><CategoryEntry><Code>CSF1R i</Code></CategoryEntry><CategoryEntry><Code>DDR i</Code></CategoryEntry><CategoryEntry><Code>EGFR i</Code></CategoryEntry><CategoryEntry><Code>EGFR T_3pi</Code></CategoryEntry><CategoryEntry><Code>ERBB2 i</Code></CategoryEntry><CategoryEntry><Code>ERBB3 i</Code></CategoryEntry><CategoryEntry><Code>ERBB4 i</Code></CategoryEntry><CategoryEntry><Code>FGFR i</Code></CategoryEntry><CategoryEntry><Code>FGFR1 i</Code></CategoryEntry><CategoryEntry><Code>FGFR2 i</Code></CategoryEntry><CategoryEntry><Code>FGFR3 i</Code></CategoryEntry><CategoryEntry><Code>FGFR4 i</Code></CategoryEntry><CategoryEntry><Code>FLT3 i</Code></CategoryEntry><CategoryEntry><Code>IGF-1R i</Code></CategoryEntry><CategoryEntry><Code>IGFR i</Code></CategoryEntry><CategoryEntry><Code>ITK i</Code></CategoryEntry><CategoryEntry><Code>JAK1 i</Code></CategoryEntry><CategoryEntry><Code>JAK1/J_tNN</Code></CategoryEntry><CategoryEntry><Code>JAK2 i</Code></CategoryEntry><CategoryEntry><Code>JAK3 i</Code></CategoryEntry><CategoryEntry><Code>KIT i</Code></CategoryEntry><CategoryEntry><Code>KSP i</Code></CategoryEntry><CategoryEntry><Code>MET i</Code></CategoryEntry><CategoryEntry><Code>MET i _mwd</Code></CategoryEntry><CategoryEntry><Code>Multi _Dz4</Code></CategoryEntry><CategoryEntry><Code>NTRK i</Code></CategoryEntry><CategoryEntry><Code>panERBB i</Code></CategoryEntry><CategoryEntry><Code>panFGFR i</Code></CategoryEntry><CategoryEntry><Code>panPDGFR i</Code></CategoryEntry><CategoryEntry><Code>PTK2 i</Code></CategoryEntry><CategoryEntry><Code>RAF1 i</Code></CategoryEntry><CategoryEntry><Code>RET i</Code></CategoryEntry><CategoryEntry><Code>ROS1 i</Code></CategoryEntry><CategoryEntry><Code>SRC i</Code></CategoryEntry><CategoryEntry><Code>SYK i</Code></CategoryEntry><CategoryEntry><Code>TEC i</Code></CategoryEntry><CategoryEntry><Code>TEK i</Code></CategoryEntry><CategoryEntry><Code>TXK i</Code></CategoryEntry><CategoryEntry><Code>VEGFR i</Code></CategoryEntry><CategoryEntry><Code>EGFR/M_YeU</Code></CategoryEntry><CategoryEntry><Code>RAF1/M_yf6</Code></CategoryEntry><CategoryEntry><Code>TYK2 i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>ras-raf-mek-erk</Name><Position>4.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>BRAF i</Code></CategoryEntry><CategoryEntry><Code>BRAF V_DlW</Code></CategoryEntry><CategoryEntry><Code>Farnes_/4N</Code></CategoryEntry><CategoryEntry><Code>KRAS G_bEF</Code></CategoryEntry><CategoryEntry><Code>KRAS G_NFM</Code></CategoryEntry><CategoryEntry><Code>KRAS m_0k2</Code></CategoryEntry><CategoryEntry><Code>MAP2K1 i</Code></CategoryEntry><CategoryEntry><Code>MAP2K2 i</Code></CategoryEntry><CategoryEntry><Code>MAP2K4 i</Code></CategoryEntry><CategoryEntry><Code>MAP3K20 i</Code></CategoryEntry><CategoryEntry><Code>MAP4K5 i</Code></CategoryEntry><CategoryEntry><Code>MEK i</Code></CategoryEntry><CategoryEntry><Code>panRAF i</Code></CategoryEntry><CategoryEntry><Code>SHP2 i</Code></CategoryEntry><CategoryEntry><Code>ERK i</Code></CategoryEntry><CategoryEntry><Code>GNAQ/G_axK</Code></CategoryEntry></CategoryEntries></Category><Category><Name>DNA damage repair</Name><Position>5.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>ATR i</Code></CategoryEntry><CategoryEntry><Code>KIF18A_X8F</Code></CategoryEntry><CategoryEntry><Code>PARP i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>developmental pathway</Name><Position>6.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>NOTCH1 ab</Code></CategoryEntry><CategoryEntry><Code>NOTCH2_kgs</Code></CategoryEntry><CategoryEntry><Code>panNotch i</Code></CategoryEntry><CategoryEntry><Code>Hedgeh_kWU</Code></CategoryEntry><CategoryEntry><Code>SMO i</Code></CategoryEntry><CategoryEntry><Code>TBL1 i</Code></CategoryEntry><CategoryEntry><Code>Porcup_PEN</Code></CategoryEntry><CategoryEntry><Code>YAP1/T_R3n</Code></CategoryEntry><CategoryEntry><Code>gamma _sbT</Code></CategoryEntry></CategoryEntries></Category><Category><Name>immune response</Name><Position>7.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>A2AR i</Code></CategoryEntry><CategoryEntry><Code>Checkp_ZL7</Code></CategoryEntry><CategoryEntry><Code>B7-H3 ab</Code></CategoryEntry><CategoryEntry><Code>CCR4 ab</Code></CategoryEntry><CategoryEntry><Code>CD47 ab</Code></CategoryEntry><CategoryEntry><Code>CD47/M_xbg</Code></CategoryEntry><CategoryEntry><Code>CD73 ab</Code></CategoryEntry><CategoryEntry><Code>CD73 i</Code></CategoryEntry><CategoryEntry><Code>CTLA4 ab</Code></CategoryEntry><CategoryEntry><Code>LAG3 ab</Code></CategoryEntry><CategoryEntry><Code>PD-1 ab</Code></CategoryEntry><CategoryEntry><Code>PD-L1 ab</Code></CategoryEntry><CategoryEntry><Code>PD-L1/_kCM</Code></CategoryEntry><CategoryEntry><Code>PD-L1/_Pp1</Code></CategoryEntry><CategoryEntry><Code>PD-L1/_LlH</Code></CategoryEntry><CategoryEntry><Code>PD-L1/_bgG</Code></CategoryEntry><CategoryEntry><Code>PD-L1 _OYR</Code></CategoryEntry><CategoryEntry><Code>TIGIT ab</Code></CategoryEntry><CategoryEntry><Code>TLR9 a_3EU</Code></CategoryEntry><CategoryEntry><Code>IFNg ab</Code></CategoryEntry><CategoryEntry><Code>IL-5 ab</Code></CategoryEntry><CategoryEntry><Code>IL-6 ab</Code></CategoryEntry><CategoryEntry><Code>IL-6R ab</Code></CategoryEntry><CategoryEntry><Code>Interferon</Code></CategoryEntry><CategoryEntry><Code>Dendri_QV0</Code></CategoryEntry><CategoryEntry><Code>Oncoly_+pe</Code></CategoryEntry><CategoryEntry><Code>Tumor _Vhd</Code></CategoryEntry><CategoryEntry><Code>Telome_f5P</Code></CategoryEntry><CategoryEntry><Code>Solubl_zyf</Code></CategoryEntry><CategoryEntry><Code>MAGEA1_KC7</Code></CategoryEntry><CategoryEntry><Code>MAGEA3_5aL</Code></CategoryEntry><CategoryEntry><Code>MAGEA4_PqO</Code></CategoryEntry><CategoryEntry><Code>CLDN6 _GIw</Code></CategoryEntry><CategoryEntry><Code>CLDN6/_YX3</Code></CategoryEntry><CategoryEntry><Code>MET CA_xe1</Code></CategoryEntry><CategoryEntry><Code>CLDN6 ab</Code></CategoryEntry><CategoryEntry><Code>CLDN6/_Di0</Code></CategoryEntry><CategoryEntry><Code>CD73/T_uJd</Code></CategoryEntry><CategoryEntry><Code>CLDN18_Sda</Code></CategoryEntry><CategoryEntry><Code>CLDN18_6NT</Code></CategoryEntry></CategoryEntries></Category><Category><Name>cell cycle</Name><Position>8.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>BCL2 i</Code></CategoryEntry><CategoryEntry><Code>CDK i</Code></CategoryEntry><CategoryEntry><Code>CDK4/6 i</Code></CategoryEntry><CategoryEntry><Code>MDM2 i</Code></CategoryEntry><CategoryEntry><Code>PLK1 i</Code></CategoryEntry><CategoryEntry><Code>TP53 a_FKn</Code></CategoryEntry><CategoryEntry><Code>TP53 Y_3az</Code></CategoryEntry><CategoryEntry><Code>WEE1 i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>other function</Name><Position>9.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>Aurora_cpG</Code></CategoryEntry><CategoryEntry><Code>Aurora_R7/</Code></CategoryEntry><CategoryEntry><Code>Aurora_R4P</Code></CategoryEntry><CategoryEntry><Code>BET i</Code></CategoryEntry><CategoryEntry><Code>BRD4 i</Code></CategoryEntry><CategoryEntry><Code>Hsp90 i</Code></CategoryEntry><CategoryEntry><Code>IDH i</Code></CategoryEntry><CategoryEntry><Code>IDH1 i</Code></CategoryEntry><CategoryEntry><Code>IDH2 i</Code></CategoryEntry><CategoryEntry><Code>MCL1 i</Code></CategoryEntry><CategoryEntry><Code>PRMT5 i</Code></CategoryEntry><CategoryEntry><Code>FAK i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>epigenetic modulation</Name><Position>10.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>DNA me_geT</Code></CategoryEntry><CategoryEntry><Code>EZH2 i</Code></CategoryEntry><CategoryEntry><Code>HDAC i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>metabolic control</Name><Position>11.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>Autoph_BhF</Code></CategoryEntry><CategoryEntry><Code>Protea_BcS</Code></CategoryEntry></CategoryEntries></Category><Category><Name>targeted immune-mediated ablation</Name><Position>12.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>CD20 ab</Code></CategoryEntry><CategoryEntry><Code>CD38 ab</Code></CategoryEntry><CategoryEntry><Code>CD52 ab</Code></CategoryEntry><CategoryEntry><Code>CLDN18_D4K</Code></CategoryEntry><CategoryEntry><Code>DLL4 ab</Code></CategoryEntry><CategoryEntry><Code>FOLR1 ab</Code></CategoryEntry><CategoryEntry><Code>mesoth_uaC</Code></CategoryEntry><CategoryEntry><Code>MUC16 ab</Code></CategoryEntry><CategoryEntry><Code>SLAMF7 ab</Code></CategoryEntry><CategoryEntry><Code>STEAP1_Vl0</Code></CategoryEntry><CategoryEntry><Code>Antith_y6u</Code></CategoryEntry><CategoryEntry><Code>PRAME _CDm</Code></CategoryEntry><CategoryEntry><Code>Surviv_BwE</Code></CategoryEntry><CategoryEntry><Code>WT1 eT_8lt</Code></CategoryEntry><CategoryEntry><Code>PMEL s_+dq</Code></CategoryEntry><CategoryEntry><Code>PRAME _t3p</Code></CategoryEntry><CategoryEntry><Code>CLDN18_v7V</Code></CategoryEntry><CategoryEntry><Code>CLDN18_VYP</Code></CategoryEntry><CategoryEntry><Code>CLDN18_Hid</Code></CategoryEntry></CategoryEntries></Category><Category><Name>BiTE</Name><Position>13.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>CD3/CD_Evx</Code></CategoryEntry><CategoryEntry><Code>CLDN18_QfG</Code></CategoryEntry><CategoryEntry><Code>DLL3 BiTE</Code></CategoryEntry><CategoryEntry><Code>FLT3 BiTE</Code></CategoryEntry><CategoryEntry><Code>MUC17/_N6N</Code></CategoryEntry><CategoryEntry><Code>PSMA BiTE</Code></CategoryEntry></CategoryEntries></Category><Category><Name>CAR-T</Name><Position>14.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>DLL3 CAR-T</Code></CategoryEntry></CategoryEntries></Category><Category><Name>targeted irradiation</Name><Position>15.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>PSMA-b_YkU</Code></CategoryEntry><CategoryEntry><Code>SSTR2-_eKN</Code></CategoryEntry><CategoryEntry><Code>SSTR3-_DCF</Code></CategoryEntry><CategoryEntry><Code>CLDN18_bKn</Code></CategoryEntry></CategoryEntries></Category><Category><Name>targeted immune pathway activation</Name><Position>16.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>PD-1/I_1wC</Code></CategoryEntry></CategoryEntries></Category><Category><Name>targeted apoptose</Name><Position>17.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>CDH17/_RZ7</Code></CategoryEntry><CategoryEntry><Code>TRAIL-_cA8</Code></CategoryEntry><CategoryEntry><Code>TRAIL-_Ays</Code></CategoryEntry></CategoryEntries></Category><Category><Name>targeted chemo</Name><Position>18.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>AXL ADC</Code></CategoryEntry><CategoryEntry><Code>BCMA ADC</Code></CategoryEntry><CategoryEntry><Code>CD19 ADC</Code></CategoryEntry><CategoryEntry><Code>CD22 ADC</Code></CategoryEntry><CategoryEntry><Code>CD228 ADC</Code></CategoryEntry><CategoryEntry><Code>CD276 ADC</Code></CategoryEntry><CategoryEntry><Code>CD30 ADC</Code></CategoryEntry><CategoryEntry><Code>CD33 ADC</Code></CategoryEntry><CategoryEntry><Code>CD37 ADC</Code></CategoryEntry><CategoryEntry><Code>CD38 ADC</Code></CategoryEntry><CategoryEntry><Code>CD46 ADC</Code></CategoryEntry><CategoryEntry><Code>CD47 ADC</Code></CategoryEntry><CategoryEntry><Code>CD48 ADC</Code></CategoryEntry><CategoryEntry><Code>CD7 ADC</Code></CategoryEntry><CategoryEntry><Code>CD70 ADC</Code></CategoryEntry><CategoryEntry><Code>CD74 ADC</Code></CategoryEntry><CategoryEntry><Code>CDH6 ADC</Code></CategoryEntry><CategoryEntry><Code>CEACAM_b5k</Code></CategoryEntry><CategoryEntry><Code>CLDN18_Gzc</Code></CategoryEntry><CategoryEntry><Code>CLDN6 ADC</Code></CategoryEntry><CategoryEntry><Code>CLEC12_G0E</Code></CategoryEntry><CategoryEntry><Code>DLL3 ADC</Code></CategoryEntry><CategoryEntry><Code>DPEP3 ADC</Code></CategoryEntry><CategoryEntry><Code>EDNRB ADC</Code></CategoryEntry><CategoryEntry><Code>EGFR ADC</Code></CategoryEntry><CategoryEntry><Code>ENPP3 ADC</Code></CategoryEntry><CategoryEntry><Code>F3 ADC</Code></CategoryEntry><CategoryEntry><Code>FCRL5 ADC</Code></CategoryEntry><CategoryEntry><Code>FGFR2 ADC</Code></CategoryEntry><CategoryEntry><Code>FGFR3 ADC</Code></CategoryEntry><CategoryEntry><Code>FLT3 ADC</Code></CategoryEntry><CategoryEntry><Code>FOLR1 ADC</Code></CategoryEntry><CategoryEntry><Code>GPNMB ADC</Code></CategoryEntry><CategoryEntry><Code>GUCY2C ADC</Code></CategoryEntry><CategoryEntry><Code>HER2 ADC</Code></CategoryEntry><CategoryEntry><Code>HAVCR1 ADC</Code></CategoryEntry><CategoryEntry><Code>MET ADC</Code></CategoryEntry><CategoryEntry><Code>IL2RA ADC</Code></CategoryEntry><CategoryEntry><Code>IL3RA ADC</Code></CategoryEntry><CategoryEntry><Code>ITGB6 ADC</Code></CategoryEntry><CategoryEntry><Code>LRRC15 ADC</Code></CategoryEntry><CategoryEntry><Code>LY6E ADC</Code></CategoryEntry><CategoryEntry><Code>LY75 ADC</Code></CategoryEntry><CategoryEntry><Code>MSLN ADC</Code></CategoryEntry><CategoryEntry><Code>MUC16 ADC</Code></CategoryEntry><CategoryEntry><Code>NECTIN_NFu</Code></CategoryEntry><CategoryEntry><Code>PTK7 ADC</Code></CategoryEntry><CategoryEntry><Code>RNF43 ADC</Code></CategoryEntry><CategoryEntry><Code>ROR1 ADC</Code></CategoryEntry><CategoryEntry><Code>ROR2 ADC</Code></CategoryEntry><CategoryEntry><Code>TF ADC</Code></CategoryEntry><CategoryEntry><Code>TFRC ADC</Code></CategoryEntry><CategoryEntry><Code>Trop2 ADC</Code></CategoryEntry><CategoryEntry><Code>SLAMF6 ADC</Code></CategoryEntry><CategoryEntry><Code>SLAMF7 ADC</Code></CategoryEntry><CategoryEntry><Code>SLC34A_LAV</Code></CategoryEntry><CategoryEntry><Code>SLITRK_FPQ</Code></CategoryEntry><CategoryEntry><Code>SSTR2 MDC</Code></CategoryEntry><CategoryEntry><Code>STEAP1 ADC</Code></CategoryEntry><CategoryEntry><Code>PSMA ADC</Code></CategoryEntry><CategoryEntry><Code>VTCN1 ADC</Code></CategoryEntry><CategoryEntry><Code>ERBB3 ADC</Code></CategoryEntry><CategoryEntry><Code>FAP ADC</Code></CategoryEntry></CategoryEntries></Category><Category><Name>targeted radio-labelling</Name><Position>19.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>GUCY2C_+vY</Code></CategoryEntry></CategoryEntries></Category><Category><Name>chemo</Name><Position>20.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>Alkyla_sSt</Code></CategoryEntry><CategoryEntry><Code>Anthra_J0M</Code></CategoryEntry><CategoryEntry><Code>Anthra_8js</Code></CategoryEntry><CategoryEntry><Code>Antime_Ci5</Code></CategoryEntry><CategoryEntry><Code>Deoxyc_iUE</Code></CategoryEntry><CategoryEntry><Code>Fluoro_BxK</Code></CategoryEntry><CategoryEntry><Code>Human _yfX</Code></CategoryEntry><CategoryEntry><Code>Immuno_GFH</Code></CategoryEntry><CategoryEntry><Code>Platin_Zg8</Code></CategoryEntry><CategoryEntry><Code>Purine_BPi</Code></CategoryEntry><CategoryEntry><Code>Pyrimi_4Q4</Code></CategoryEntry><CategoryEntry><Code>Taxane</Code></CategoryEntry><CategoryEntry><Code>Topois_pQ4</Code></CategoryEntry><CategoryEntry><Code>Triazene</Code></CategoryEntry><CategoryEntry><Code>Vinca _lhR</Code></CategoryEntry><CategoryEntry><Code>Chemot_6GS</Code></CategoryEntry></CategoryEntries></Category><Category><Name>(anti)hormonal</Name><Position>21.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>5 alph_xa8</Code></CategoryEntry><CategoryEntry><Code>Antian_O3e</Code></CategoryEntry><CategoryEntry><Code>Aromat_S/m</Code></CategoryEntry><CategoryEntry><Code>Endocr_Klf</Code></CategoryEntry><CategoryEntry><Code>Estrog_PZx</Code></CategoryEntry><CategoryEntry><Code>GnRH a_Qii</Code></CategoryEntry><CategoryEntry><Code>GnRH a_oGK</Code></CategoryEntry><CategoryEntry><Code>Nonste_gLU</Code></CategoryEntry><CategoryEntry><Code>Select_unq</Code></CategoryEntry><CategoryEntry><Code>Somato_VHG</Code></CategoryEntry><CategoryEntry><Code>Steroi_iBc</Code></CategoryEntry><CategoryEntry><Code>Steroi_DAe</Code></CategoryEntry></CategoryEntries></Category><Category><Name>hematologic</Name><Position>22.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>C5 ab</Code></CategoryEntry><CategoryEntry><Code>Factor_hUl</Code></CategoryEntry><CategoryEntry><Code>Factor_xas</Code></CategoryEntry><CategoryEntry><Code>vWF me_mhC</Code></CategoryEntry><CategoryEntry><Code>CXCR4 i</Code></CategoryEntry><CategoryEntry><Code>Granul_YGi</Code></CategoryEntry><CategoryEntry><Code>Granul_CfP</Code></CategoryEntry><CategoryEntry><Code>Hemato_Yfm</Code></CategoryEntry><CategoryEntry><Code>Megaka_c7Y</Code></CategoryEntry><CategoryEntry><Code>Phosph_gXo</Code></CategoryEntry></CategoryEntries></Category><Category><Name>supportive</Name><Position>23.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>diarrheal</Code></CategoryEntry><CategoryEntry><Code>RANKL ab</Code></CategoryEntry><CategoryEntry><Code>Antifolate</Code></CategoryEntry><CategoryEntry><Code>Appeti_KCH</Code></CategoryEntry><CategoryEntry><Code>Bispho_o7J</Code></CategoryEntry><CategoryEntry><Code>Cannab_5ag</Code></CategoryEntry><CategoryEntry><Code>Dopami_FyA</Code></CategoryEntry><CategoryEntry><Code>Emesis_xBZ</Code></CategoryEntry><CategoryEntry><Code>NK1 an_QX8</Code></CategoryEntry><CategoryEntry><Code>Phenot_Vgt</Code></CategoryEntry><CategoryEntry><Code>Seroto_9Ql</Code></CategoryEntry><CategoryEntry><Code>Steroid</Code></CategoryEntry><CategoryEntry><Code>Trypto_Ddl</Code></CategoryEntry><CategoryEntry><Code>Uric a_mxm</Code></CategoryEntry></CategoryEntries></Category><Category><Name>NSAID</Name><Position>24.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>COX-1 i</Code></CategoryEntry><CategoryEntry><Code>COX-2 i</Code></CategoryEntry></CategoryEntries></Category><Category><Name>(anti)coagulant</Name><Position>25.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>GPIIb-_FHC</Code></CategoryEntry><CategoryEntry><Code>Antico_fhO</Code></CategoryEntry><CategoryEntry><Code>Coagul_HRt</Code></CategoryEntry><CategoryEntry><Code>Direct_FhF</Code></CategoryEntry><CategoryEntry><Code>Direct_SLk</Code></CategoryEntry><CategoryEntry><Code>Factor_KVW</Code></CategoryEntry><CategoryEntry><Code>GPIIb-_z3Q</Code></CategoryEntry><CategoryEntry><Code>Hemost_9zc</Code></CategoryEntry><CategoryEntry><Code>P2Y12 _mGY</Code></CategoryEntry><CategoryEntry><Code>Ultral_NNQ</Code></CategoryEntry><CategoryEntry><Code>Vitami_MnA</Code></CategoryEntry></CategoryEntries></Category><Category><Name>antimicrobial</Name><Position>26.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>Antiba_jr0</Code></CategoryEntry><CategoryEntry><Code>Antifungal</Code></CategoryEntry><CategoryEntry><Code>Antiviral</Code></CategoryEntry><CategoryEntry><Code>Fluoro_6AE</Code></CategoryEntry><CategoryEntry><Code>PCP pr_KxU</Code></CategoryEntry><CategoryEntry><Code>Penicillin</Code></CategoryEntry><CategoryEntry><Code>Viral _zGK</Code></CategoryEntry></CategoryEntries></Category><Category><Name>other</Name><Position>27.0</Position><Auswahldialog>true</Auswahldialog><EntryCount>27</EntryCount><Beschreibung/><CategoryEntries><CategoryEntry><Code>Antihi_pja</Code></CategoryEntry><CategoryEntry><Code>Antile_K6C</Code></CategoryEntry><CategoryEntry><Code>Antips_9Ug</Code></CategoryEntry><CategoryEntry><Code>Antipy_2vI</Code></CategoryEntry><CategoryEntry><Code>Benzod_BWO</Code></CategoryEntry><CategoryEntry><Code>Chemot_S7O</Code></CategoryEntry><CategoryEntry><Code>Diuretic</Code></CategoryEntry><CategoryEntry><Code>PDE i</Code></CategoryEntry><CategoryEntry><Code>Xanthi_bAH</Code></CategoryEntry><CategoryEntry><Code>IMPDH2 i</Code></CategoryEntry></CategoryEntries></Category></Categories></Version></Versions><Ordner><Bibliothek><Name>Benutzer Bibliothek</Name></Bibliothek><Name>NCT-POT Drugs</Name><Typ>1</Typ><ParentOrdner><Bibliothek><Name>Benutzer Bibliothek</Name></Bibliothek><Name>MASTER Onkostar 2.0</Name><Typ>1</Typ></ParentOrdner></Ordner></PropertyCatalogue></Editor></OnkostarEditor>
